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Abstract 
In the human population, many immune- and nausea-related illnesses are more prevalent 
in women, relative to men.However, this apparent difference in not currently considered 
in animal research. The major question of this thesis was whether this sex difference 
could be reflected in a rodent model. Furthermore, how does immune system stimulation 
with LPS affect learning and memory in females? This thesis examined sex differences in 
the establishment of lithium chloride (LiCl) – induced conditioned disgust behavior 
(anticipatory nausea) to a distinct context, as well as, the establishment of conditioned 
place avoidance (CPA) using rodent models. Also examined were potential sex 
differences in response to treatment with the bacterial endotoxin, lipopolysaccharide 
(LPS), and its effect on learning and memory. In Chapter 2, male and female naïve Long-
Evans rats were injected (intraperitoneally; i.p.) with either 200 µg/kg LPS or 0.9% 
(NaCl), 90 minutes prior to i.p. injections of either 128 mg/kg LiCl or 0.9% NaCl, and 
immediately placed into a distinctive context for 30 minutes (repeated over 4 
conditioning days, spaced 72 h apart). 72 h following the final conditioning day, each 
subject was re-exposed to the context on a drug-free test day where orofacial and somatic 
behaviors were recorded. Results showed that LiCl-treated females conditioned stronger 
disgust reactions, relative to LiCl-treated males, as evidenced by significantly higher 
frequencies of conditioned “gaping” behavior and forelimb flailing in females. Pre-
treatment with LPS during conditioning led to strong inhibition of conditioned disgust 
behavior, to levels that did not significantly differ from controls. Although there was no 
apparent sex difference in the degree of inhibition produced by LPS in this context-based 
rodent disgust model, males did exhibit significantly greater 24 h body weight losses 
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following LPS injections on the first two conditioning days, relative to females. In 
Chapter 3, the sex difference in conditioned gaping behavior found in Chapter 2 was 
explored further by examining potential dose-related effects. Once again, females 
displayed significantly higher frequencies of conditioned “gaping” behavior relative to 
males, in a dose-dependent manner. The results from Chapters 2 and 3 provide strong 
support for a sex difference in the onset and severity of nausea-related symptoms which 
is also observed among the human population. This provides a preclinical tool for testing 
the efficacy of anti-nausea treatments and noxious drug side-effects. 
In Chapter 4, the effects of LPS pretreatment on the establishment of conditioned place 
avoidance (CPA) were examined. Female rats were also injected with LPS or saline 
during the peripubertal phase of development (6 weeks of age) and later pretreated with 
LPS again or saline in the classic two-chamber CPA paradigm. Results showed that while 
peripubertal LPS had no long-term effect on establishing CPA, it did interfere with the 
ability of a second LPS challenge in adulthood to block CPA, as was shown in subjects 
pretreated with LPS in adulthood only. The results of this study demonstrated a 
significant sex difference in the acquisition of conditioned disgust (i.e., anticipatory 
nausea), and the importance of considering the peripubertal stage of development when 
evaluating the effects of environmental challenges on adult behavior. 
Keywords 
Lithium Chloride (LiCl); Lipopolysaccharide (LPS); Anticipatory Nausea (AN); 
Conditioned Disgust; Rat; Sex Differences; Conditoned Place Avoidance (CPA); 
Conditioned Taste Avoidance; Conditioned Taste Aversion (CTA): Learning; Memory; 
Inhibition; Peripubertal; Homotypic; Sickness Behavior; Oncology; Model 
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1  General Introduction 
In the human population, sex differences in the incidence and severity of certain 
mental and physical health disorders are not uncommon, especially in conditions 
characterized by nausea and/or inflammation-associated pathophysiology (Klein, 2012). 
For example, women report more frequent and severe experiences with nausea, relative to 
men, which include increased susceptibility to motion sickness (MSS; Paillard et al., 
2013), increased nausea in relation to the onset of chronic migraine (CM; Özge et al., 
2014), severe post-operative nausea and vomiting (PONV; Fujii, 2009), and, higher 
incidences of anticipatory nausea and vomiting (AN/V) in oncology patients receiving 
chemotherapy treatment (Fetting et al., 1983; Hilarius et al., 2012; LeBaron et al., 1988; 
Williams et al., 1980). Women also comprise 60% and 80% of the populations suffering 
from asthma (Tam et al., 2011) and autoimmune disease (Voskuhl, 2011), respectively; 
and, are 2-6 x more likely to die from H5N1 Avian influenza, relative to men (Klein, 
Pekosz, Passaretti, Anker, & Olukoya, 2010). Furthermore, a greater incidence of 
anxiety/depression-related disorders (for review, see Altemus, Sarvaiya & Epperson, 
2014), as well as, neurodegenerative disease (For review, see Rocca, Mielke, Vemuri & 
Miller, 2014), are observed in women- all of which have been associated with pro-
inflammatory pathology (Abbott et al., 2015; Raz, Knoefel & Bhaskar, 2016; 
Vivekanantham et al., 2015).  
Since there are clear sex differences in nausea- and inflammation-related 
disorders observed in the human population, it is crucial that animal researchers employ 
models that reflect these important differences when examining disease etiology and/or 
treatment. However, the vast majority of research is carried out in male subjects only, 
thus reducing the potential validity of the model itself, and increasing the likelihood that 
putative treatments are less efficacious within a population comprised of both males and 
females. Therefore, the examination of nausea- and inflammation-related behaviors in 
female animal subjects is a critical factor for elucidating the mechanisms of these 
phenomena.  
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1.1 Nausea and learning 
Nausea is a feeling of importance in human and animal medicine, which is poorly 
understood. Feelings of nausea are subjective and described as an unpleasant internal 
state (Kenward et al., 2015), consisting of queasiness or feeling sick to the stomach 
(Koch, 1995). Severe nausea and/or vomiting occurs in 40 – 70% of patients in palliative 
care, which greatly reduces patient quality of life (Keeley, 2009). Nausea also commonly 
presents following the intake of toxic or intolerable substances (Bischoff and Renzer, 
2006), as an adverse post-operative side effect (Fujii, 2009), as a core symptom of motion 
sickness (Golding, 2006; Matchock et al., 2008; Paillard et al., 2013), or, as a side-effect 
to pharmacotherapy treatment, including chemotherapy (Morrow et al., 2002; 
Molassiotis, 2005).  
Feelings of nausea play a large role in the development of conditioned disgust-
related behavior. Conditioned taste aversion/avoidance is a behaviorally adaptive form of 
learning that enables animals to successfully reject or avoid consumption of potentially 
harmful food agents (Garcia, Lasiter, Bermudez-Rattoni, & Deems, 1985). Gustatory 
conditioning to solutions paired with (Eckel & Ossenkopp, 1996; Kent, Cross-Mellor, 
Kavaliers, & Ossenkopp, 2000; Ossenkopp & Eckel, 1995; Spector, Breslin, & Grill, 
1988) or foods infused with (Cross-Mellor, Clarke, & Ossenkopp, 2004; Loy & Hall, 
2002; Ossenkopp & Eckel, 1995; Ossenkopp, Ladowsky, & Eckel, 1997) an emetic toxin 
is acquired rapidly and can be very robust. It is important to note the distinction between 
taste aversion and taste avoidance. A conditioned taste aversion has been established 
when animals exhibit active aversive rejection responses (i.e., gapes, forelimb flails, head 
shakes, passive drip, and chin rubs) to an intraoral infused taste that was previously 
paired with a nausea-inducing US, such as LiCl (see Parker, 2003). The taste reactivity 
test (TRT) is commonly employed to test for conditioned taste aversion. This test 
involves the involuntary infusion (via intraoral cannula) of a salient taste that was 
previously paired with feelings of nausea during the conditioning phase (Berridge, Grill, 
& Norgren, 1981; Grill & Norgren, 1978 a,b). Upon infusion of the salient taste, animals 
will display aversion-related rejection responses to the taste, in the absence of any actual 
noxious treatment. A conditioned taste avoidance has been established when an animal 
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refuses to voluntarily consume a salient taste that was previously paired with a nausea-
inducing US (e.g., LiCl). In the classic two-bottle preference test for conditioned taste 
avoidance, animals previously infused with a palatable taste in conjunction with feelings 
of nausea will, in a drug-free state, prefer to drink a safe fluid, such as water, and avoid 
consumption of the taste originally associated with nausea during the conditioning phase 
(e.g., Rana & Parker, 2008). 
Although rats are incapable of vomiting (Borison, 1989; Hatcher, 1924, Horn et 
al., 2013), they do produce a gaping response that is similar to the orofacial topography 
of the retch response exhibited by the shrew, Suncus murinus, just prior to an emetic 
response (see Parker et al., 2008; Parker & Limebeer, 2006). Gaping is defined as the 
repeated opening and closing of the lower mandible in rapid succession approximately 5-
7 times, and it involves the same musculature as the shrew retch (Travers & Norgren, 
1986). Conditioned disgust was initially demonstrated in rats by pairing a novel taste with 
the effects of a nausea-inducing emetic drug, such as lithium chloride (LiCl). Garcia et al. 
(1974) argued that the rat disgust behaviors of gaping and chin rubbing, observed in 
response to the conditioned taste cue following such conditioning, were established by an 
association between the taste and activation of emetic neural circuitry, such as the 
brainstem emetic chemoreceptor trigger zone (area postrema; Borison, 1989).   
By quantifying the rat orofacial and somatic behaviors when challenged with an 
intraoral infusion of the conditioned taste in a drug free test, Grill and Norgren (1978a) 
demonstrated that the disgust behaviors of gaping, chin rubbing and paw treading, were a 
strong index of conditioned taste aversions.  Other studies have found that only emetic 
drugs condition gaping responses (Parker et al., 2006), and that the taste conditioned 
disgust response of gaping can be reduced or eliminated by lesioning the area postrema in 
rats (Eckel & Ossenkopp, 1996; Ossenkopp & Eckel, 1994, 1995), or, by treating the rats 
with anti-emetic drugs, such as ondansetron and 8-OH-DPAT (Limebeer & Parker, 2000; 
Parker et al., 2008).   
In addition to the establishment of taste + illness associations, rodents have also 
been shown to associate a distinct context with “feelings” of nausea, induced by the toxin 
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LiCl, which models anticipatory nausea responses in human oncology patients receiving 
chemotherapy treatment. Anticipatory nausea (AN) is commonly observed among 
individuals receiving chemotherapy treatment for cancer, who report anticipatory nausea 
and/or vomiting to be among the most aversive side-effects from chemotherapy treatment 
(Morrow et al., 2002), oftentimes causing them to reduce or forego potentially life-saving 
treatment. Produced by classical conditioning, AN is acquired following exposure to a 
novel context-based conditioned stimulus (CS) (e.g., exposure to a hospital environment) 
that was paired with a nausea/emesis-inducing unconditioned stimulus (US) (e.g., 
chemotherapy treatment) (Morrow et al., 2002; Molassiotis, 2005). Anticipatory nausea is 
acquired when, upon subsequent re-exposure(s) to the contextual environment (CS), 
nauseous/emetic conditioned responses (CR) are exhibited prior to actual drug treatment.  
Anticipatory nausea conditioning can be modeled in the rodent by means of a 
“conditioned gaping” learning and memory paradigm. As stated, “conditioned gaping” 
behavior has been shown to be an index of nausea in the rat, evidenced by the prevention 
of LiCl-induced conditioned gaping when rats are administered an anti-emetic treatment, 
such as, ondansetron or the 5-HT1A agonist 8-OH-DPAT (Limebeer et al., 2006; 
Limebeer et al., 2008; Parker and Limebeer, 2006). Furthermore, it has been shown that a 
distinct context, previously paired with LiCl-induced nausea, has the potential to 
establish a conditioned taste aversion when this context is paired with a novel saccharin 
flavor (i.e., second-order conditioning), in the absence of any direct pairing with LiCl 
(Sticht et al., 2015). This evidence demonstrates that the conditioned disgust responses 
(i.e., gaping) to the context CS are indicative of feelings of nausea, as nausea is 
specifically required for the formation of true conditioned taste aversions (see Parker, 
2003; Chambers, 2015). 
Exposure to a context previously associated with feelings of nausea elicits a 
“conditioned gaping” response in the rat, providing an animal model that can serve as a 
valuable preclinical tool for examining anticipatory nausea treatments in chemotherapy 
patients (Limebeer et al., 2006; Limebeer et al., 2008; Molassiotis, 2005). Thus, rats can 
learn and remember associations between distinctive environments and experienced 
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nausea, and subsequently retrieve these associations to show aversion-related behaviors, 
such as gaping, upon re-exposure to the environment (Limebeer et al., 2006, 2008). 
Similar to AN, in the 2-chamber test for Conditioned Place Avoidance (CPA; (see 
Frisch et al., 1995, Miller et al., 2000, Parker, 1992, Turenne et al., 1996 and White and 
Carr, 1985), rodents learn to associate one of two distinct chambers with the effects of 
drug treatment (e.g., LiCl-induced nausea), while the other “safe” chamber is paired with 
a saline control. These context + illness/saline pairings are alternated over the course of 
the Conditioning Phase. On a drug-free Test Day, each animal is re-exposed to the 
previously drug-paired chamber, and allowed to escape into the previously saline-paired 
chamber through a new opening between the two contexts. Male rats display significant 
LiCl-induced CPA behavior, spending less time in the previously drug-paired chamber 
relative to saline controls, and displaying dose-dependent increases in vertical rearing 
behavior (Tenk et al., 2005).  
To date, potential sex differences in the conditioning of nausea/disgust responses 
in rodents have not been closely examined. Previous studies indicate that human females 
condition anticipatory nausea more often and in greater strength, relative to males; 
however, this sex difference has not yet been examined in the rodent models of 
anticipatory nausea (i.e., context aversion) and conditioned place avoidance. 
1.2 Immune system stimulation 
Accumulating evidence suggests that both bacterial and viral infections can have 
diverse behavioral and physiological effects. These effects include the production of an 
adaptive profile of behaviors termed “sickness behavior”, as well as, reported deleterious 
effects on learning and memory in some, but not all, paradigms. Lipopolysaccharide 
(LPS), the active component of Gram-negative bacteria outer cell wall (Dinarello, 1984), 
is used to mimic bacterial infections. Administration of LPS stimulates the immune 
system, thus activating phagocytes and resulting in the release of pro-inflammatory 
cytokines. Cytokines, such as, interleukin-1 beta (IL-1β), tumor necrosis factor alpha 
(TFN-α), and interleukin-6 (IL-6), produce a specific set of behaviors collectively known 
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as “sickness behavior”. The sickness behavior profile often includes, fever (Hart, 1988; 
O’Reilly et al., 1988; Roth et al., 1997), decreased locomotor activity (Hart, 1988; 
Engeland et al., 2003 a; Franklin et al., 2007; Yirmiya et al., 1994), hypersomnia and 
decreased grooming (Hart, 1988), adipsia, and anorexia (Cross-Mellor et al., 2000; Gayle 
et al., 1998; Langhans, 2000; Langhans et al., 1990), all of which are considered to be 
behaviorally adaptive and serve to help the organism counter the bacterial infection. 
 Bacteria-related immunogens have been shown to affect learning and memory in 
a variety of learning paradigms. However, the results from previous studies, which have 
examined the effects of acute versus chronic LPS administration on learning and 
memory, have been somewhat inconsistent. It has been reported that marked learning 
deficits are observed following LPS-treatment in the Morris water maze (MWM) (Arai et 
al., 2001; Shaw et al., 2001; Sparkman et al., 2005 b), yet others have reported slower 
swimming speeds that may account for longer search latencies to the hidden platform 
(Sparkman et al., 2005b). However, performance deficits in the MWM have been shown 
to be associated with disruptions in NMDA-dependent, and NMDA-independent long-
term potentiation, following chronic intracerebroventricular administration of LPS (Min 
et al., 2009).  Similarly, it has been suggested that LPS may impair the ability to form 
representations of distinct contexts in contextual fear conditioning paradigms, as 
demonstrated by a reduction in freezing responses upon re-exposure to a context 
previously paired with an aversive foot shock in LPS-treated rats and mice (Kranjac et 
al., 2012; Pugh et al., 1998).  
Learning paradigms that require the animal to produce significant motor output 
present potential confounds to the interpretation of task performance. As LPS is known to 
produce reductions in locomotor behavior (Franklin et al., 2007; Hart, 1988; Yirmiya et 
al., 1994) during the acute-phase response to endotoxin treatment, it can be difficult to 
determine whether learning decrements are a product of disruptions in cognitive 
processes or simply due to reductions in locomotor behavior (Cunningham & Sanderson, 
2008). Indeed, it has been suggested that the effects of LPS on learning and memory must 
be tested in different paradigms that do not present such potential confounding factors 
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(Cunningham & Sanderson, 2008). Thus, the investigation of LPS effects on learning and 
memory in rodent conditioned disgust paradigms is of interest. 
The rodent models of taste aversion/avoidance, anticipatory nausea, and 
conditioned place avoidance utilize the rat’s ability to associate the aversive feelings of 
toxin-associated nausea with distinct tastes or contexts. LPS pre-treatment during the 
conditioning phase of the AN and CTA paradigms has been shown to significantly 
attenuate the establishment of conditioned disgust responses (e.g., gaping, paw treading, 
chin rubbing).  Treatment with LPS has been shown to produce an initial drop in 
voluntary saccharin (Yirmiya, 1996; Langhans, 1996) or sucrose (Cross-Mellor et al., 
1999) consumption. The act of feeding involves both appetitive and consummatory 
factors (see Parker, 2003 for review). In a taste avoidance paradigm, intake is voluntary, 
and thus both appetitive and consummatory factors are involved. Since LPS produces 
anorexia and adipsia during the acute-phase response, there is often little motivation to 
consume liquids or food (i.e., appetite). Thus, it would follow that without appetite, 
voluntary consumption would be low as well. In the conditioned taste aversion paradigm, 
which uses the involuntary TRT, appetite is not a factor in terms of intrinsic motivation to 
drink, therefore only consummatory factors are being evaluated (Parker, 2003). 
The results of prior studies demonstrate that LPS by itself does not produce 
conditioned taste aversion, instead, it has been shown to block robust conditioned taste 
aversion that is typically produced through the pairing of an emetic treatment (i.e., LiCl) 
and a palatable sucrose solution (Cross-Mellor et al., 2009). Male rats pre-treated with 
LPS during LiCl conditioning also fail to acquire robust conditioned “gaping” responses 
in the rodent model of AN, displaying similar behavioral frequencies to saline controls 
(Chan et al., 2009; Chan et al., 2013; Cloutier et al., 2011; Cloutier et al., 2012b).  
The effects of LPS treatment on CPA learning have not yet been evaluated in 
male or female subjects. Likewise, the effects of LPS pre-treatment on the establishment 
of AN in have not yet been examined in female subjects. Furthermore, since LPS 
developmental models are now being used to elucidate potential links between early-life 
(i.e., prenatal or neonatal) infection and mental illness, it is of interest to examine the 
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consequence of immune challenges during other sensitive periods of development, such 
as, puberty, on learning and memory in adulthood. Female mice treated with LPS at 6 
weeks of age have been shown to develop long-term alterations in behavior, displaying 
increased plasma concentrations of estradiol, and surprisingly, increased anxiety-like 
behavior (Blaustein et al., 2011). Neonatal male rat pups treated with LPS displayed 
exacerbated sickness behavior responses to homotypic challenge in adulthood, while 
females did not (Tenk et al., 2008). Thus, it is clear that the long-term effects of LPS 
treatment on behavior may be dependent, in part, on biological sex. However, the effects 
of a peripubertal immune challenge on learning and memory in adulthood have not yet 
been examined. 
 
1.3 Objectives of the current thesis 
 Conditioned disgust and other aversion-related behaviors that become associated 
with salient conditioning stimuli have been studied for decades, though data from female 
subjects is scarce. Given the evident human sex differences in the incidences of nausea- 
and inflammation-related ailments, the need for female subjects as animal models is 
therefore fundamental to the understanding of disease etiology and treatment.  
The first objective of this thesis was to examine the ability of female rodents to 
process and to associate an external mode of stimulus presentation (i.e., a distinct 
context) with an internal sickness cue (i.e., LiCl-induced nausea) in the rodent model of 
Anticipatory Nausea (i.e, conditioned place aversion), and to test whether a significant 
sex difference was present. The second part of this study examined the effects of pre-
treatment with lipopolysaccharide, during the 4-day AN Conditioning Phase, on the 
expression of learning and memory deficits on the Drug-Free Test Day, in order to 
elucidate any further sex differences in the response to LPS effects on learning and 
memory. 
 The second objective of this thesis was to further investigate the sex difference 
observed in the first study, where it was shown that female rats conditioned significantly 
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higher frequencies of conditioned disgust-related behavior, relative to males. In this 
second experiment, sex differences in the dose response to LiCl-induced AN were 
examined. Adult male and female rats were treated with one of three doses of LiCl (64 
mg/kg, 96 mg/kg, or 128 mg/kg), or, a saline control, prior to immediate exposure to a 
distinct context over a 4-day Conditioning Phase. Dose- and sex-dependent increases in 
conditioned disgust behavior (e.g., “conditioned gaping”) were examined. 
 The third objective of this thesis was to examine, for the first time, Conditioned 
Place Avoidance behavior in female rats using a 2-chamber CPA apparatus, wherein one 
distinct chamber is paired with LiCl-induced nausea, and the other distinct chamber is 
paired with saline. Acute LPS pre-treatment, during the 8-day CPA Conditioning Phase, 
and its effects on establishing CPA behavior were also examined in females. To the best 
of our knowledge, this is the first time the effects of LPS on CPA learning have been 
examined in any rodent. LPS challenge during sensitive developmental phases, such as, 
the neonatal and peripubertal stages, has been shown to produce long-lasting alterations 
in behavior. Therefore, the effect of a single immune system challenge with LPS on CPA 
learning in adulthood was examined. Futhermore, long-term changes in the response to a 
second homotypic drug challenge in adulthood were also evaluated. 
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Chapter 2 
2 Rodent sex differences in disgust behaviors 
(anticipatory nausea) conditioned to a context 
associated with the effects of the toxin LiCl: Inhibition of 
conditioning following immune stimulation with 
Lipopolysaccharide 
Chemotherapy treatment plays a major role in cancer survival rates; however, its 
cytotoxicity produces undesirable side effects, including severe acute and delayed nausea. 
This aversive nausea experience serves as an unconditioned stimulus in the establishment 
of a phenomenon termed Anticipatory Nausea and/or Vomiting (AN/V). Anticipatory 
nausea presents as a classically conditioned response, produced by the pairing of the 
hospital treatment room or context with the nausea produced by the chemotherapy, 
resulting in the establishment of a robust conditioned nausea/vomiting response upon re-
entry into the hospital context on subsequent visits, prior to actual drug treatment (Hickok 
et al., 2003). It is estimated that 30% of patients suffer from conditioned anticipatory 
nausea, and report it as the most aversive component of chemotherapy treatment 
(Rodriguez, 2013). Due to the severity of this conditioned response, patient non-
compliance increases as many choose to forego further treatment that could be life-saving 
(Molassiotis, 2005).  
Anticipatory nausea conditioning can be modeled in rodents by means of 
“conditioned disgust” learning and memory paradigms. Although rats are incapable of 
vomiting (Borison, 1989; Hatcher, 1924, Horn et al., 2013), they do produce a gaping 
response which is similar to the orofacial topography of the retch response exhibited by 
the shrew, Suncus murinus, just prior to an emetic response (see Parker et al., 2008; 
Parker & Limebeer, 2006), and involves the same musculature (Travers & Norgren, 
1986). Conditioned disgust was initially demonstrated in rats by pairing a novel taste with 
the effects of a nausea-inducing emetic drug, such as lithium chloride (LiCl). Garcia et al. 
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(1974) argued that the rat disgust behaviors of gaping and chin rubbing, observed in 
response to the conditioned taste cue following such conditioning, were established by an 
association between the taste and activation of emetic neural circuitry, such as the 
brainstem emetic chemoreceptor trigger zone (area postrema; Borison, 1989).  By 
quantifying the rat orofacial and somatic behaviors when challenged with an intraoral 
infusion of the conditioned taste in a drug free test, Grill and Norgren (1978a) 
demonstrated that the disgust behaviors of gaping, chin rubbing and paw treading, were a 
strong index of conditioned taste aversions.  Other studies have found that only emetic 
drugs condition gaping responses (Parker et al., 2006), and that the taste conditioned 
disgust response of gaping can be reduced or eliminated by lesioning the area postrema in 
rats (Eckel & Ossenkopp, 1996; Ossenkopp & Eckel, 1994, 1995), or, by treating the rats 
with anti-emetic drugs, such as ondansetron and 8-OH-DPAT (Limebeer & Parker, 2000; 
Parker et al., 2008).   
Exposure to a context previously associated with feelings of nausea elicits not 
only a robust conditioned context place avoidance (e.g., Tenk et al., 2005), but also a 
conditioned disgust response (gaping) and this paradigm has been offered as an animal 
model of anticipatory nausea (see Limebeer et al., 2006; Parker et al., 2008). Dose related 
increases in rat gaping behavior have been observed in a drug free test trial following 
multiple pairings of a novel context with the effects of LiCl (Ossenkopp et al., 2011). 
Thus, rats can learn and remember associations between distinctive environments and 
experienced nausea, and subsequently retrieve these associations to show aversion-related 
behaviors, such as gaping, upon re-exposure to this environment (Limebeer et al., 2008). 
This model can serve as a valuable preclinical tool for examining anticipatory nausea in 
chemotherapy patients (Limebeer et al., 2008; Molassiotis 2005; Parker et al., 2008). As 
this population comprises one third of all patients undergoing chemotherapy treatment, 
individual differences, such as sex differences, in AN/V should be examined in order to 
determine the possible reasons why some patients establish strong anticipatory nausea, 
while others do not. 
In addition to examining sex differences in the establishment of conditioned 
disgust, it is also important to evaluate sex differences in the efficacy of drug treatments 
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that have been shown to disrupt learning and memory in these paradigms. 
Lipopolysaccharide (LPS) treatment is an experimental procedure that has been shown to 
reduce or abolish the conditioning of disgust responses to novel taste or context cues in 
rats (Chan et al., 2009, 2013; Cloutier et al., 2012a,b; Cross-Mellor et al., 2009). LPS is 
the active component of the cell wall of Gram negative bacteria, and when injected into 
an animal results in the production of pro-inflammatory cytokines (Dinarello, 1984), 
chiefly interleukin-1 beta (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor alpha 
(TNF-α). LPS treatment also initiates a specific set of pathophysiological and behavioral 
changes collectively known as “sickness behaviors”. These “sickness behaviors” include 
induction of fever (Hart, 1988; O’Reilly et al., 1988; Roth et al., 1997), anorexia and 
adipsia (Cross-Mellor et al., 2000; Gayle et al., 1998; Langhans, 2000; Langhans et al., 
1990), reductions in locomotor activity (Hart, 1988; Engeland et al., 2003 a; Franklin et 
al., 2007; Yirmiya et al., 1994), hypersomnia and reduction in grooming (Hart, 1988), 
helping the organism counter the bacterial infection. 
LPS treatment has been found to have deleterious effects in some learning and 
memory paradigms. Studies have found effects on the consolidation phase in contextual 
fear conditioning, context discrimination, and two-way active avoidance learning (e.g., 
Pugh et al., 1998; Kranjac et al., 2012; Sparkman et al., 2005a). However, the nature of 
the sickness behaviors produced by LPS treatment can make it difficult to separate 
cognitive effects from changes in locomotor output. For example, some studies have 
shown learning and memory impairments in spatial reference learning in the Morris water 
maze (Arai et al., 2001; Shaw et al., 2001; Sparkman et al., 2005b) and in the radial arm 
maze (Song et al., 2004). However, other studies have considered the influence of LPS-
induced reductions in locomotor output on spatial performance and have concluded that 
latencies to reach the hidden platform in LPS-treated rats are due to decreased swimming 
speeds, as opposed to increased distances travelled to reach the platform (Sparkman et al., 
2005b). The conditioned disgust (gaping) paradigm is not influenced by locomotor 
reductions (Grill and Norgren, 1978b). 
The conditioned disgust rodent model of anticipatory nausea has to date only used 
male subjects. In the human population, anticipatory nausea occurs more frequently in 
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female patients (Fetting et al., 1983; Hilarius et al., 2012; LeBaron et al., 1988). Thus, it 
was of interest to examine the conditioning of nausea related disgust responding in 
female rats. Females also exhibit enhanced immune functioning, relative to males (e.g., 
Bilbo & Nelson, 2001; Engeland et al., 2003a,b; Gaillard & Spinedi, 1998; Lahita, 2000), 
and such effects on learning and memory require further examination. The current study 
investigated the effects of treatment with the bacterial endotoxin LPS on the 
establishment of LiCl conditioned disgust reactions in both male and female rats. As 
women exhibit anticipatory nausea more frequently than men, it was predicted that a sex 
difference in the frequency of conditioned disgust responses would be observed, 
evidenced by a higher frequency of conditioned disgust reactions in the female rats, 
relative to the males. Given this specific objective of the present study, a priori pairwise 
comparisons for sex differences in conditioned disgust behaviors were applied.  
Secondly, as females show enhanced immune functioning, relative to males, it was 
predicted that a sex difference in response to LPS treatment would be observed in terms 
of acute phase sickness behaviors (less weight loss) during conditioning and in its effects 
on learning (less reduction in conditioned disgust responses). 
2.1 Materials and Methods 
2.1.1 Subjects 
Subjects were 29 male and 31 female adult naive Long-Evans rats (Charles River, 
Quebec, Canada) weighing between 175-250 g at the start of the experiment. The rats 
were pair-housed in standard polypropylene cages (45 x 22 x 20 cm) in a colony room 
with a temperature of 21 ± 1 °C and maintained on a 12-h light: 12-h dark cycle with the 
lights on from 07:00 to 19:00 h. All rats had free access to food (ProLab RMH 3000 rat 
chow) and tap water throughout the experiment. The experimental methodology was 
carried out according to the Canadian Council on Animal Care guidelines and was 
approved by the University of Western Ontario Animal Care Sub-Committee. 
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2.1.2 Apparatus 
The apparatus (used on all conditioning days and the test day) consisted of a white 
Plexiglas box (29 cm × 25 cm × 29 cm) set atop a clear glass plate. A mirror was 
mounted at a 45° angle beneath the glass plate in order to view the rat’s ventral surface. 
Two 40 W red lights were placed below the glass plate (see Figure 1B). Lighting cues 
were kept consistent with previous studies employing this rodent model of anticipatory 
nausea (e.g., Chan et al., 2009). Behavioral responses exhibited on the Drug-Free Test 
Day were videotaped with a video camera (Sony DCR-DVD201; London, Ontario) 
positioned approximately 1 m from the mirror. 
2.1.3 Experimental procedure 
An illustration of the testing injection schedule and group designation is provided 
in Figure 1A-B and Table 1. All conditioning and testing was performed during the light 
phase of the LD cycle. The experiment consisted of two phases, included a Conditioning 
Phase (4 days, spaced 72 h apart), and one Drug-free Test Day, 72 h following the final 
conditioning day. There were four experimental groups for each sex resulting in 8 groups 
(n = 7-8/group) in total. 
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Day         1 2     3     4 5     6     7 8     9     10 11     12     13
Conditioning Phase
Days 1, 4, 7, 10
Drug-free Test Day
Re-exposed to context for 10 minutes
Pre-Treatment
200 µg/kg LPS
or
0.9% NaCl
Treatment
128 mg/kg LiCl
or
0.9% NaCl
Returned to 
home cage for 
90 minutes
Immediate 
exposure to 
context for 
30 minutes
A 
B
 
Figure 1 A-B. Procedure. Rats were pretreated with LPS or saline followed 90 
minutes later by an injection of either LiCl or saline, and quickly placed into a 
distinctive context for 30 minutes, on each conditioning day. On the drug-free test 
day, each rat was reexposed to the distinctive context for 10 minutes. 
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Pre-Treatment Treatment Group Name Male n = Female n = 
0.9% NaCl 0.9% NaCl NaCl-NaCl 7 8 
0.9% NaCl 128 mg/kg LiCl NaCl-LiCl 8 8 
200 µg/kg LPS 0.9% NaCl LPS-NaCl 7 8 
200 µg/kg LPS 128 mg/kg LiCl LPS-LiCl 7 7 
Table 1. Group designation.  
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2.1.3.1 Conditioning phase drug treatment 
On each day of the Conditioning Phase (4 days, 72 h apart), animals were pre-
treated with an intraperitoneal injection of either 200 µg/kg LPS or an equal volume of 
0.9% isotonic saline (NaCl; 1 ml/kg), 90 minutes prior to a second intraperitoneal 
injection of 128 mg/kg lithium chloride (LiCl; 20 ml/kg; 0.15 M), or 0.9% isotonic saline 
(NaCl; 20 ml/kg). Each rat was then immediately placed into the distinctive context for 
30 minutes. Following each exposure to the distinctive context, animals were 
immediately returned to the home cage. The eight groups consisted of: LPS-LiCl, LPS-
NaCl, NaCl-LiCl, and NaCl-NaCl, for both males and females. An illustration of the 
group composition is shown in Figure 1C. Doses of LiCl and LPS were selected based on 
previous findings that demonstrated robust conditioned gaping behavior following 
treatment with 128 mg/kg LiCl, and significant impairment of conditioned gaping 
responses using 200 µg/kg LPS (Chan et al., 2009; Cloutier et al., 2012; Chan et al., 
2013). 
2.1.3.2 Change in Body Weight 
 Body weight was measured prior to conditioning and again 24 h later on 
each of the four conditioning days. LPS induces an acute-phase response, wherein the 
initial immune system stimulation produces a specific set of sickness behaviors that 
includes anorexia and adipsia. The anorectic and adipsic effects lead to significant weight 
loss following LPS treatment (Hart, 1988; Li et al., 2000) - a reliable measure of LPS 
influence.  
  2.1.3.3 Drug-free test day 
 72 h following the final Conditioning Day, each animal was again placed in the 
distinctive context for 10 minutes in a drug-free state, and behavioral responses were 
video recorded for later scoring. Dependent behavioral variables analyzed consisted of 
the frequency of the active aversive disgust-related behaviors; “gaping”, forelimb flailing, 
chin rubbing, head shaking, and paw treading (see Grill & Norgren, 1978a). Gaping was 
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defined as lowering of the mandible and the pushing or thrusting out of the lower teeth 
(see Parker & Limebeer, 2006). 
  2.1.3.4 Vaginal lavage collection 
 After arriving from the supplier, the animals were allowed one week to 
acclimatize to the colony room before being handled. Following handling over 3 days, 
the estrous cycle was tracked daily, at the same time each day throughout the experiment. 
Vaginal lavages were collected with a pipette filled with distilled warm water, and 
samples were placed onto microscope slides for later analysis in order to determine the 
cycle phase of each rat on the drug-free test day. 
 2.1.4 Data analysis 
  2.1.4.1 Changes in body weight 
Following LPS treatment, significant reductions in body weight are typically observed 24 
h post-treatment, relative to controls (Li et al., 2000). Percent of body weight change was 
calculated by subtracting the Conditioning Day body weight from the 24 h post-treatment 
weight, then dividing by the Conditioning Day body weight and multiplying by 100.  
Percent change in body weight was analyzed with a repeated-measures split-plot 
Analysis of Variance (ANOVA), with 3 between-subjects factors: Sex (at 2 levels: Male 
or Female), Drug 1 (at 2 levels: LPS or NaCl), and Drug 2 (at 2 levels: LiCl or NaCl); 
and, one within-subjects factor: Conditioning Day (at 4 levels: C1-C4).  
Post-hoc pairwise comparisons were performed using Tukey’s Honestly 
Significant Difference (HSD) test. All statistical tests used a significance criterion 
of α = 0.05. 
  2.1.4.2 Drug-free test day 
 On the 10-minute drug-free Test Day frequency of gaping responses, paw 
treading, forelimb flailing, and head shaking were each analyzed using a between-
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subjects ANOVA with 3 between-subjects factors: Sex (at 2 levels: Male or Female), 
Drug 1 (at 2 levels: LPS or NaCl), and Drug 2 (at 2 levels: LiCl or NaCl).  
As this part of the study was exploratory, Fisher’s least significant difference 
(LSD) test was used for a priori and post-hoc pairwise comparisons. All statistical tests 
used a significance criterion of α = 0.05.  
2.2 Results  
 Results showed that all rats treated with LiCl (i.e., males and females in Group 
NaCl-LiCl) established robust conditioned gaping behavior, relative to controls. 
Furthermore, females acquired stronger condtioned disgust responses relative to males. 
LPS blocked the formation of conditioned gaping behavior in both sexes, with no 
significant differences observed between sexes. 
2.2.1 Body weight 
The ANOVA revealed significant main effects of Conditioning Day, F(3, 119) = 
37.693, p< 0.001; Sex, F(1, 52) = 19.375, p< 0.001; and, Drug 1 (LPS or NaCl), F(1, 52) 
= 64.562, p< 0.001. Significant interactions were revealed for Sex x Drug 1, F(1, 52) = 
4.240, p< 0.05; Conditioning Day x Sex, F(3, 119) = 3.387, p< 0.05; Conditioning Day x 
Drug 1, F(3, 119) = 51.019, p< 0.001; and, Conditioning Day x Sex x Drug 1, F(3, 119) 
= 4.326, p< 0.02. 
Post hoc analyses (Tukey’s HSD) revealed that, 24 h following Conditioning Day 
1, all LPS-treated male and female groups lost significantly more body weight relative to 
all saline control groups (p’s< 0.01). Furthermore, both LPS-treated groups of males lost 
significantly more body weight relative to females in Group LPS-NaCl (p’s< 0.05), but 
not relative to females in Group LPS-LiCl. Twenty-four hours following Conditioning 
Day 2, males in Group LPS-LiCl lost significantly more weight relative to female Groups 
LPS-LiCl and NaCl-LiCl only (p’s< 0.05). Whereas LPS-treated males continued to 
show small body weight decreases, LPS-treated females exhibited body weight increases 
following Conditioning Day 2. No other significant differences in weight loss were found 
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in LPS-treated subjects, relative to controls, following Conditioning Days 3 and 4. Mean 
percent change in body weight and S.E.M. are depicted in Figure 2. 
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Figure 2 A-B. Mean (+ S.E.M.) percent change in body weight over four conditioning days for 
groups NaCl-NaCl, NaCl-LiCl, LPS-NaCl, and LPS-LiCl (males and females; n = 7-8/group). 24 
h following Conditioning Day 1 (Fig. 2B), all LPS-pretreated groups lost significantly more body 
weight relative to NaCl controls (p’s< 0.05). LPS-pretreated males also lost significantly more 
weight than females in Group LPS-NaCl (p< 0.05). 
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2.2.2 Drug-free test day 
All Test Day data presented reflect conditioned responding only, while the animal 
was in a completely drug-free state.  
 2.2.2.1 Conditioned gaping behavior 
The between-subjects ANOVA revealed significant main effects of Drug 1 (LPS or 
NaCl), F(1, 52) = 19.26, p< 0.001; and, Drug 2 (LiCl or NaCl), F(1, 52) = 25.74, p< 
0.001, on the frequency of conditioned the disgust reaction of gaping. In addition, a 
significant Drug 1 x Drug 2 interaction was found, F(1, 52) = 19.05, p< 0.001. No other 
significant main effects or interactions were found. 
 A priori analyses (Fisher’s LSD) for sex differences revealed that both males and 
females in Group NaCl-LiCl established conditioned disgust, evidenced by gaping 
frequencies that were significantly higher than those displayed by males and females in 
Groups NaCl-NaCl, LPS-NaCl, and LPS-LiCl (p’s < 0.02). Thus, LPS pre-treatment 
prior to LiCl treatment blocked the establishment of conditioned gaping behavior in both 
males and females. Most notably, females in Group NaCl-LiCl displayed higher 
frequencies of conditioned gaping relative to males in Group NaCl-LiCl (p< 0.02), 
evidence for a significant sex difference in the establishment of conditioned gaping 
responses. Mean gaping frequencies and S.E.M. are depicted in Figure 3.  
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Figure 3. Mean (+ S.E.M.) frequency of conditioned “gaping” behavior expressed by 
Groups NaCl-NaCl, NaCl-LiCl, LPS-NaCl, and LPS-LiCl (males and females; n = 7-
8/group) during the 10-minute test in the distinctive context in the absence of drug 
treatment. Both males and females in Group NaCl-LiCl displayed significantly higher 
“gaping” frequencies relative to controls. * denotes that females in Group NaCl-LiCl also 
displayed significantly higher “gaping” frequencies relative to males in Group NaCl-LiCl 
(p< 0.05).  
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2.2.2.2 Conditioned forelimb flails 
The between-subjects ANOVA revealed significant main effects of Sex, F(1, 52) 
= 7.91, p< 0.01; Drug 1 (LPS or NaCl), F(1, 52) = 6.24, p< 0.02; and, Drug 2 (LiCl or 
NaCl), F(1, 52) = 13.07, p = 0.001, on the frequency of conditioned forelimb flailing 
behavior. Significant interactions were also found for Sex x Drug 1, F(1, 52) = 4.32, p< 
0.05; Sex x Drug 2, F(1, 52) = 4.32, p< 0.05; Drug 1 x Drug 2, F(1, 52) = 10.44, p< 0.01; 
and, Sex x Drug 1 x Drug 2, F(1, 52) = 7.907, p< 0.01. 
 A priori analyses (Fisher’s LSD) for sex differences revealed that females 
in Group NaCl-LiCl displayed significantly more forelimb flails relative to all other 
groups, including a sex difference when compared to males in Group NaCl-LiCl (p’s< 
0.001), which did not differ from controls. Mean frequencies of forelimb flailing and 
S.E.M. are depicted in Figure 4.  
 
 
 
36 
 
 
 
Conditioned Forelimb Flails
Group
NaCl-NaCl LPS-NaCl NaCl-LiCl LPS-LiCl
M
e
a
n
 F
re
q
u
e
n
c
y
 o
f 
B
e
h
a
v
io
r
0
1
2
3
4
5
Male
Female*
*
*
 
 
 
 
Figure 4. Mean (+ S.E.M.) frequency of conditioned forelimb flailing behavior expressed 
by Groups NaCl-NaCl, NaCl-LiCl, LPS-NaCl, and LPS-LiCl (males and females; n = 7-
8/group) during the 10-minute test in the distinctive context in the absence of drug 
treatment. Females in Group NaCl-LiCl displayed significantly higher forelimb flailing 
frequencies relative to controls. *** denotes that females in Group NaCl-LiCl also 
displayed significantly higher “gaping” frequencies relative to males in Group NaCl-LiCl 
(p< 0.001). 
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2.2.2.3 Conditioned chin rubs 
The ANOVA indicated significant main effects for Drug 1, F(1,52) = 12.34, p = 
0.001, and Drug 2, F(1,52) = 12.78, p = 0.001, as well as a significant Drug 1 x Drug 2 
interaction F(1,52) = 12.34, p = 0.001. Post-hoc comparisons indicated that both the male 
and female groups NaCl-LiCl exhibited significantly higher levels of chin rubbing 
relative to all other groups (ps < .02) but there was no sex difference in these two groups 
or any other comparisons (see Figure 5).  
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Figure 5. Mean (+ S.E.M.) frequency of conditioned chin rubbing behavior 
expressed by Groups NaCl-NaCl, NaCl-LiCl, LPS-NaCl, and LPS-LiCl (males 
and females; n = 7-8/group) during the 10-minute test in the distinctive context 
in the absence of drug treatment. ** and *** indicate that NaCl-LiCl males and 
females displayed significantly higher frequencies of conditioned chin rubbing 
relative to all other groups (p’s< 0.01 and 0.001, respectively). 
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2.2.2.4 Conditioned paw treads 
 The ANOVA showed significant main effects for Drug 1, F(1,52) = 7.08, p = 0.01 
and Drug 2, F(1,52) = 10.94, p < .01, as well as a significant Drug 1 x Drug 2 interaction, 
F(1,52) = 7.81, p < .01. Again, post-hoc comparisons indicated that both the male and 
female groups NaCl-LiCl exhibited significantly higher levels of paw treading relative to 
all other groups (ps < .02) except the female LPS-LiCl group. As well, there was no sex 
difference in any comparisons (see Figure 6). 
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Figure 6. Mean (+ S.E.M.) frequency of conditioned paw treading behavior expressed by 
Groups NaCl-NaCl, NaCl-LiCl, LPS-NaCl, and LPS-LiCl (males and females; n = 7-
8/group) during the 10-minute test in the distinctive context in the absence of drug 
treatment. * and ** indicate that NaCl-LiCl males and females displayed significantly 
higher frequencies of conditioned paw treading relative to all other groups (p’s< 0.05 and 
0.01, respectively), except Female Group LPS-LiCl. 
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2.2.2.5 Conditioned head-shakes 
 No significant main effects or interactions were obtained in the ANOVA for the 
head-shake data (data not shown). Post-hoc comparisons also failed to reveal any 
significant group differences. 
 2.2.3 Vaginal Lavage 
 Following coding of the lavage samples under the microscope (magnification 
10x), it was noted that, in each group, there was a relatively even distribution of cycle 
phases across group members Furthermore, since conditioning occurred every 72 h, each 
animal experienced one conditioning day on each day of the estrous cycle. Therefore, the 
samples in each group were pseudo-randomized, and not selected for, based on cycle 
phase. In addition, no disruptions to cycle phase were observed in any females following 
any drug treatment. 
2.3 Discussion 
 Results of the present study showed that female rats (Group NaCl-LiCl) 
conditioned stronger disgust reactions (i.e., higher frequencies of “gaping” and forelimb 
flailing) to a distinct context, relative to male rats (Group NaCl-LiCl). This finding is 
consistent with previously observed sex differences in the human population (Fetting et 
al., 1983; Hilarius et al., 2012; LeBaron et al., 1988). Pre-treatment with LPS during the 
Conditioning Phase led to significant reductions in 24 h body weight following LPS 
treatment, in both male and female groups (Groups LPS-LiCl and LPS-NaCl). However, 
LPS-treated males lost significantly more body weight on the first two Conditioning Days 
relative to LPS-treated females. This finding is consistent with previous studies showing 
that, during the light phase, locomotor decrements (i.e., acute-phase response sickness 
behavior) are less pronounced in female rats, relative to males (Engeland et al., 2003 b; 
Franklin et al., 2006). Despite a sex difference in the acute-phase response following 
systemic LPS treatment, there was no apparent behavioral sex difference in the ability of 
LPS to disrupt the establishment of conditioned disgust reactions in this model. Both 
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LPS-treated males and females failed to establish significant frequencies of conditioned 
disgust behavior (Group LPS-LiCl), relative to saline pre-treated controls (Groups NaCl-
LiCl and NaCl-NaCl). These results provide strong evidence of a sex difference in the 
establishment of conditioned disgust behavior in the rat, as well as, differences in 
response to immune system stimulation with LPS. The results of the current study are 
discussed further in the following sections.  
2.3.1 Body weight change 
Consistent with prior reports (Chan et al., 2009; Engeland et al., 2003a,b) 
treatment with LPS produced significant decreases in body weight, relative to saline pre-
treated groups, 24 hours following Conditioning Days 1 and 2. Although some significant 
differences between groups were observed following Conditioning Days 3 and 4, the data 
show that LPS pre-exposed animals did, in fact, gain weight, though not at the same rate 
as saline pre-treated animals. This index of systemic LPS tolerance development 
(significantly decreased physiological effects of LPS with repeated treatment) is 
consistent with tolerance effects to LPS observed in previous studies (e.g., Cross-Mellor 
et al., 1999; Dantzer, 2004; Engeland et al., 2001; Engeland et al., 2003 a,b). 
Male rats pre-treated with LPS (Groups LPS-NaCl and LPS-LiCl) lost 
significantly more body weight 24 h following treatment on Conditioning Days 1 and 2, 
relative to LPS-treated females. These findings add further evidence of a sex difference in 
the behavioral response to LPS treatment. Female rats develop tolerance to LPS 
treatment, but this tolerance does not develop as strongly if the two initial treatments are 
each administered during the proestrus phase of the estrous cycle (Engeland et al., 2006). 
A previous study has also shown that, during the light phase of the light-dark (LD) cycle, 
males showed greater locomotor decrements relative to females (Franklin et al., 2003). In 
the current study, conditioning episodes were carried out during the light cycle every 3 
days which ensured a different estrous cycle day for females on each of the 4 
conditioning days. Furthermore, estrous cycle phases for each rat in each group were 
pseudo-randomized (i.e., a relatively even number of rats began conditioning in each 
phase of the estrous cycle) across the estrous cycles.  
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2.3.2 Context-conditioned disgust behaviors  
Pre-treatment with saline (NaCl) followed by LiCl treatment (male and female 
Groups NaCl-LiCl) during the conditioning phase resulted in the robust conditioned 
“gaping” behavior, relative to all other groups, when re-exposed to the conditioning 
context on a drug-free test day. This finding is consistent with prior reports demonstrating 
that rats can associate “feelings” of nausea with a specific context and display 
anticipatory nausea (conditioned “gaping” behavior) when placed in the context in a 
drug-free state (Chan et al., 2009; Cloutier et al., 2012a,b; Limebeer et al., 2006; 
Ossenkopp et al., 2011). Furthermore, the present study expands on these previous 
findings by showing a significant sex difference in the degree of conditioned disgust 
responses, evidenced by higher frequencies of conditioned “gaping” behavior and 
forelimb flailing in female rats, relative to males. Rats lack an emetic reflex (e.g., Horn et 
al., 2011), but display a conditioned disgust reaction when exposed to tastes or contexts 
previously associated with nausea (Limebeer et al., 2006). Forelimb flailing is an active 
aversive behavior most often displayed during conditioned taste aversion testing with the 
Taste Reactivity Test (TRT; see Grill & Norgren, 1978a; Parker, 2003). Although this 
behavior is most commonly observed during the TRT with aversive tastes, it also has 
been observed (along with paw treading, chin rubbing and head shaking) during the 10-
minute drug-free test for context-based conditioned disgust (i.e., anticipatory nausea) 
(Limebeer et al., 2006). In the present study only gaping, forelimb flailing, chin rubbing 
and paw treading behaviors were conditioned to the distinct context with LiCl treatment, 
and only gaping and forelimb flailing exhibited significant sex differences. 
2.3.3 Effects of immune system stimulation with LPS 
 Pre-treatment with LPS in both male and female LiCl-treated groups led to 
significant inhibition of all conditioned disgust behaviors. The current study used a 
relatively large dose of LPS (200 µg/kg) which may have resulted in a ceiling effect in its 
ability to inhibit learning and memory. LPS-treated females displayed significantly less 
body weight loss on conditioning Days 1 and 2, relative to males, but there was no sex 
difference in the degree of inhibition of the conditioned disgust responses. Future studies 
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should investigate the effects of lower doses of LPS on the establishment of conditioned 
disgust, in order to explore possible sex differences in the degree of inhibition of learning 
and memory. 
2.3.4 Putative mechanisms 
The acquisition of anticipatory nausea relies on the association of feelings of 
nausea with a specific context, thus, it is likely that this task is largely hippocampus-
dependent (Kranjac et al., 2012; Limebeer et al., 2006). It is the consequential innate 
immune response, not the LPS itself, that leads to behavioral changes. While LPS does 
not readily cross the blood-brain-barrier, toll-like receptors (e.g., TLR-4) are found to be 
expressed in brain endothelium cells, thus increasing BBB permeability, and triggers a 
series of events ultimately leading to a central inflammatory response (see Singh & Jiang, 
2004). Peripheral and central routes of administration could bring about different 
outcomes, but one is not wholly distinct from the other, and thus, both should be 
considered. In addition, the link between endotoxin administration and LiCl treatment on 
vagal afferent activity should be addressed. Firstly, although LiCl stimulates various 
vagal afferents, the vagus nerve is not necessary for the establishment of conditioned 
disgust responses (Niijima & Yamamoto, 1994). In fact, sympathetic nerve activity is 
more important for relaying LiCl sensory information relative to vagal afferents (Niijima 
& Yamamoto, 1994), and vagotomy does not disrupt the establishment of CTA (Martin et 
al., 1978). The evidence for the role of the vagus nerve in peripheral and central cytokine 
relationships is in debate. Conflicting evidence suggests that while vagotomy blocks 
sleep enhancement induced by systemic TNF-α and LPS (Zielinski et al., 2012), other 
studies suggest that vagotomy fails to block LPS-induced fever (Hansen et al., 2000), nor 
is the vagus nerve the major pathway by which abdominal IL-1β and LPS affect 
behavioral, hypothalamic-pituitary-adrenal (HPA) axis, and brain catecholamine 
responses (Wieczorek et al., 2005). 
 Here, we discuss the putative mechanisms of LPS-induced memory disruptions in 
the form of inhibited consolidation processes in the hippocampus. Indeed, there is 
evidence suggesting that LPS treatment inhibits aversion conditioning by disrupting 
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memory consolidation processes. Examination of LPS-induced chronic 
neuroinflammation on the induction of NMDA-dependent, and NMDA-independent, 
long-term potentiation (LTP) shows that intracerebroventricular administration of LPS 
produces significant spatial memory impairment in the Morris water maze (Min et al., 
2009). LPS treatment also impaired the ability to form representations of distinct contexts 
in a contextual fear conditioning paradigm, as demonstrated by a reduction in freezing 
responses upon re-exposure to a context previously paired with an aversive foot shock in 
LPS-treated rats (Pugh et al., 1998). In both studies, it was suggested that LPS could 
affect the functioning of the hippocampus. Recordings of postsynaptic potentials showed 
that the induction of NMDA-dependent and NMDA-independent LTP were impaired in 
the Schaffer collateral-CA1 synapse of the hippocampus (Min et al., 2009). 
Contextual fear conditioning has been shown to be, at least in part, a 
hippocampus-dependent learning paradigm, as demonstrated by the elimination of 
contextual fear conditioned responses after hippocampal lesions one day following 
conditioning (Kim & Fanselow, 1992). Tanaka et al. (2006) reported that LPS 
administration to the CA1 region of the hippocampus activated microglial cells and 
resulted in an increased production of IL-1β and TNF-α in this region. After 5 days of 
injections, it was found that long-term activation of microglia, induced by LPS, resulted 
in a decrease of glutamatergic transmission and learning and memory impairments 
without neuronal cell death (Tanaka et al., 2006). 
Kranjac et al. (2012) showed that a single LPS injection, following contextual fear 
conditioning training, not only impaired memory consolidation, but could also disrupt 
memory reconsolidation processes in mice. This was evidenced by a decrease in freezing 
responses in LPS-treated mice, along with heightened peripheral and central cytokine and 
chemokine levels, and significantly decreased brain-derived neurotrophic factor (BDNF) 
mRNA expression in the hippocampus and cortex (Kranjac et al., 2012).  
It has been shown that peripheral inflammation by LPS causes a reduction of 
trophic supply in the brain (Schnydrig et al., 2007). Neurotrophins, such as BDNF and 
nerve growth factor (NGF), are known to play an important role in synaptic plasticity and 
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long-term potentiation (Schnydrig et al., 2007). An experiment by Hennigan, Trotter, & 
Kelly (2007) demonstrated that synaptic plasticity in the dentate gyrus of the 
hippocampal complex is related to neurotrophin signaling changes, and that the 
disruption of these changes in plasticity by LPS may be partially due to a strong effect on 
these signaling cascades. Guan and Fang (2006) found that LPS treatment decreased 
BDNF expression in not only the hippocampus, but also the frontal, parietal, temporal, 
and occipital cortices. LPS also exerts a depressive effect on the expression of other 
neurotrophins, such as, NGF and neurotrophic factor 3 (NT-3), where expression was 
significantly reduced in cortical regions, as well as, the hippocampus (Guan & Fang, 
2006).  
The results of the studies discussed above strongly suggest that treatment with 
LPS, or specific cytokines, such as IL-1β, disrupts memory consolidation processes that 
are vital for associative learning in paradigms, such as those for anticipatory nausea and 
taste avoidance. Furthermore, these neurotrophin data also suggest that, although 
tolerance develops to the systemic effects of LPS treatment (i.e., reduction in behavioral 
sickness behaviors), it seems to have longer lasting central effects. Indeed, it has 
previously been shown that systemically LPS-tolerant animals failed to acquire LiCl-
induced context-conditioned disgust (anticipatory nausea) when treated with LPS during 
conditioning (Chan et al., 2013).  
There is evidence for a sex difference in hippocampus-dependent cognition and 
neurogenesis (Duarte-Guterman et al., 2015), where sex steroids, such as, estradiol and 
progesterone, have been implicated in learning and memory processes. Ovariectomy has 
been shown to impair cognitive function across different tasks; and, depending on the 
experimental parameters (e.g., age, strain, task), estradiol replacement has been shown to 
reverse overiectomy-induced deficits (for review, see Gibbs, 2010; Hogervorst et al., 
2000). Estrogens have been shown to influence hippocampus-dependent memory in tasks 
that typically demonstrate a sex difference in performance, such as, spatial and context 
learning paradigms (Duarte-Guterman et al., 2015). Increases in the proliferation of new 
neurons in the hippocampus, and facilitation of hippocampal-dependent learning and 
memory, have been observed following acute estradiol treatment (Barha et al., 2010; 
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Mahmoud et al., 2016). Some evidence suggests that the effects of estrogen on 
neurogenesis are decreased by a single dose of progesterone administered 24 hours 
following estradiol treatment (Tanapat et al., 2005). While acute administration of 
estradiol into ovariectomized rats has been shown to improve context-dependent 
memory, chronic treatment with estradiol has been shown to have no effect on the 
acquisition of such tasks, such as, contextual fear conditioning (Barker & Galea, 2010). 
Importantly, when evaluating the influence of sex steroids on learning and memory, 
many factors need to be considered, such as, age, species, dosing schedule, type of task, 
and type of estrogen employed (Duarte-Guterman et al., 2015). In the current study, 
hormone concentrations were not measured, thus, the influence of gonadal hormones on 
the acquisition of conditioned disgust cannot be determined. However, in the present 
experiment, female subjects were conditioned during different phases of the estrous cycle 
with no apparent influence of cycle phase on the establishment of conditioned disgust 
behavior (i.e., “gaping” and forelimb flailing). Future research should investigate the 
influence of cycle phase and differing hormone concentrations on the acquisition of 
toxin-induced context-based conditioned disgust reactions.  
2.3.5 Conclusions 
 It was hypothesized that female rats would condition stronger conditioned disgust 
responses relative to males, in the rodent model of anticipatory nausea (AN), and that 
pre-treatment with the immune system stimulant, lipopolysaccharide , would 
differentially inhibit this conditioning in male and female rats. It was found that female 
rats exhibited significantly stronger conditioned disgust (gaping and forelimb flailing) to 
a context paired with LiC treatments than did males. Although LPS significantly 
inhibited LiCl-induced context conditioned disgust behaviors in both males and females, 
there was no evidence of a significant sex difference in the degree of this inhibition. 
Further investigation is required to replicate and expand on the finding of this novel sex 
difference in anticipatory nausea, and to elucidate whether LPS has significantly different 
effects on the male and female brain during learning and memory for aversive internal 
states. The present findings are consistent with sex differences observed within the 
human oncology population that conditions AN, providing further validation of this 
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rodent model and its preclinical use in the evaluation sex differences in response to anti-
emetic/anti-nausea drug treatments. 
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Chapter 3 
3 A sex difference in the expression of conditioned 
disgust behaviors (anticipatory nausea) to a context 
previously paired with the toxic effects of LiCl in the rat: 
A toxin dose-response examination 
Nausea is a feeling of importance in human and animal medicine, which is poorly 
understood. Feelings of nausea are subjective and described as an unpleasant internal 
state (Kenward et al., 2015), consisting of queasiness or feeling sick to the stomach 
(Koch, 1995). Severe nausea and/or vomiting occurs in 40 – 70% of patients in palliative 
care, which greatly reduces patient quality of life (Keeley, 2009). Nausea also commonly 
presents following the intake of toxic or intolerable substances (Bischoff and Renzer, 
2006), as an adverse post-operative side effect (Fujii, 2009), as a core symptom of motion 
sickness (Golding, 2006; Matchock et al., 2008; Paillard et al., 2013), or, as a side-effect 
to pharmacotherapy treatment, including chemotherapy (Morrow et al., 2002; 
Molassiotis, 2005). The study of nausea, and the need for valid animal models, is 
therefore crucial, given the problems nausea presents in health care and medicine. 
Individual differences in sex, age, family environment, and personality traits have 
also been associated with the incidence of nausea. Sex differences in incidence and 
severity of nausea have been reported in studies examining Motion Sickness 
Susceptibility, Chronic Migraine, and Post-Operative Nausea and Vomiting. It has been 
shown that females have higher Motion Sickness Susceptibility relative to males (Paillard 
et al., 2013). Furthermore, it has been observed that fluctuating estrogen levels over the 
menstrual cycle may influence the severity or likelihood of motion sickness-related 
nausea. Peaks in nausea occur during the peri-menses phase, relative to the peri-ovulatory 
phase, but this effect is not observed among women using oral contraceptives (Matchock 
et al., 2008). Nausea is also reported as a main contributing factor to Chronic Migraine 
Syndrome more often in females, relative to males (Özge et al., 2014); and, female sex is 
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one of the main predictors of Post-Operative Nausea and Vomiting (Fujii, 2009). Taken 
together, these findings suggest that there are sex differences in the experience of nausea. 
Thus, sex is an important factor to consider when modeling nausea in animals in order to 
examine the efficacy of anti-nausea drug therapy, nausea-related side-effects of 
therapeutic drug treatment, and, the mechanisms underlying the conditioning of nausea 
responses. One particular example is that of anticipatory nausea and vomiting in 
oncology patients receiving cytotoxic chemotherapy treatment, who report nausea to be 
the most aversive side effect of the treatment (Morrow et al., 2002). 
Chemotherapy treatment plays a major role in cancer survival rates, however its 
cytotoxicity produces undesirable side-effects, including severe acute and delayed 
nausea. Such nausea can lead to the establishment of Anticipatory Nausea and/or 
Vomiting (AN/V). AN/V presents as a classically conditioned phenomenon (Stockhorst 
et al., 2006; Bovbjerg, 2006), where the pairing of a conditioned stimulus (e.g., a novel 
hospital context) with the unconditioned stimulus (nausea produced by chemotherapy) 
leads to the establishment of a robust conditioned nausea/vomiting response upon re-
entry into the hospital context on subsequent visits, prior to actual drug treatment 
(Morrow et al., 2002; Molassiotis, 2005). Due to the severity of this conditioned 
response, patient non-compliance with treatment increases and many choose to forego 
further treatment that could be life-saving (Morrow et al., 2002). Reports estimate that 
30% of patients suffer from conditioned anticipatory nausea (Rodriguez, 2013).  
Within the subset of individuals who condition AN/V, case reports and cohort 
studies suggest a higher incidence in females relative to males, including both 
adolescents and adults (Williams et al., 1980; Fetting et al., 1983; LeBaron et al., 1988; 
Hilarius et al., 2012). It is possible that anxiety related to such factors as alopecia and 
amenorrhea (in adolescent females), or the greater willingness in females to express 
feelings, may contribute to this apparent sex difference (LeBaron et al., 1988). However, 
other evidence suggests that sex differential experiences with nausea may also have an 
innate component. 
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The subjectivity of the feeling of nausea presents a challenge when developing 
animal models for examination of nausea-related responses. Rodent models of 
conditioned nausea and disgust have been successfully developed by using “conditioned 
gaping” learning and memory paradigms (Limebeer et al., 2006, 2008). “Conditioned 
gaping” behavior has been shown to be a useful index of nausea in the rat, evidenced by 
the prevention of LiCl-induced conditioned gaping when rats are administered anti-
emetic treatments, such as, ondansetron or the 5-HT1A agonist 8-OH-DPAT (Limebeer et 
al., 2006; Limebeer et al., 2008; Parker and Limebeer, 2006). As well, the orofacial 
component of the “retch” reflex that precedes vomiting in shrews is topographically 
similar to the rat “gape” response (Parker and Limebeer, 2006; Parker et al., 2008), 
requiring the same musculature as the rat gape (Travers and Norgren, 1986).  
Re-exposure to a salient sucrose or saccharin taste that was previously paired with 
nausea elicits conditioned aversion-related disgust responses, such as gaping, in the taste 
reactivity test (TRT) for conditioned taste aversion (Grill and Norgren, 1978). Exposure 
to a specific context that has previously become associated with feelings of toxin-induced 
nausea can also elicit robust conditioned disgust (gaping) responses in the rat, providing a 
rodent model that can serve as a valuable preclinical tool for examining anticipatory 
nausea treatments in chemotherapy patients (Limebeer et al., 2006; Limebeer et al., 2008; 
Molassiotis, 2005). Thus, rats can learn and remember associations, not only between 
distinctive tastes and experienced nausea, but also between distinctive contexts that were 
previously paired with nausea, and they can subsequently retrieve these associations to 
show aversion-related disgust behaviors, such as gaping, upon re-exposure to the context 
in a drug-free state. Furthermore, it has been shown that a distinct context, previously 
paired with LiCl-induced nausea, has the potential to establish a conditioned taste 
aversion when this context is paired with a novel saccharin flavor (i.e., second-order 
conditioning), in the absence of any direct pairing with LiCl (Sticht et al., 2015a). This 
evidence demonstrates that the conditioned disgust responses (i.e., gaping) to the context 
CS are indicative of feelings of nausea, as nausea is specifically required for the 
formation of true conditioned taste aversions (see Parker, 2003; Chambers, 2015). 
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Female sex is a predictor of not only nausea-related phenomena, such as, motion 
sickness susceptibility, chronic migraine, and post-operative nausea (Fujii, 2009; 
Matchock et al., 2008; Özge et al., 2014, Paillard et al., 2013) but also appears to be a 
predictive factor in the development of anticipatory nausea and vomiting following 
chemotherapy treatment (Williams et al., 1980; Fetting et al., 1983; LeBaron et al., 1988; 
Hilarius et al., 2012). It is thus of interest to examine potential sex differences in the 
establishment of anticipatory nausea in the rodent model. Such information would allow 
for further improvements in anti-emetic and anti- nausea treatments, drug side-effects, 
and possible elucidation of neural mechanisms of nausea responses and how these are 
influenced by individual differences. The rodent model of anticipatory nausea has to date 
mainly been evaluated in male subjects, and sex differences in conditioned disgust 
responses to salient contexts have not yet been evaluated extensively.  
The present study examined potential dose-related sex differences in conditioned 
disgust reactions, using four different doses of the nausea-inducing toxin, LiCl: 0 mg/kg 
(NaCl control), 64 mg/kg, 96 mg/kg, and 128 mg/kg. Based on reported sex differences 
in nausea responses in the human population it was hypothesized that adult female rats 
would exhibit stronger conditioned nausea responses (higher frequencies of conditioned 
disgust behaviors), relative to adult males. 
3.1 Material and methods 
3.1.1 Subjects 
Subjects were 37 male and 39 female adult naive Long-Evans rats (Charles River, 
Quebec, Canada) weighing between 175-250 g at the start of the experiment. The rats 
were pair-housed in standard polypropylene cages (45 x 22 x 20 cm) in a colony room 
with a temperature of 21 ± 1 °C. The colony room was maintained on a 12-h light: 12-h 
dark cycle with the lights on from 07:00 to 19:00 h. All rats had free access to food 
(ProLab rat chow RMH 3000) and tap water throughout the experiment. Rats were 
acclimatized to the colony room for one week and were then handled on three separate 
days. The experimental methodology was carried out according to the Canadian Council 
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on Animal Care guidelines and was approved by the University of Western Ontario 
Institutional Animal Care Committee. 
  
3.1.2 Apparatus 
The apparatus (used on all conditioning days and the test day) consisted of a white 
Plexiglas box (29 cm × 25 cm × 29 cm) set atop a clear glass plate. A mirror was 
mounted at a 45° angle beneath the glass plate in order to view the rat’s ventral surface. 
Two 40 W red lights were placed below the glass plate. Lighting cues were kept 
consistent with those used in previous studies employing this rodent model of 
anticipatory nausea (e.g., Chan et al., 2009; Cloutier et al., 2011). Behavioral on the 
Drug-Free Test Day were videotaped with a video camera (Sony DCR-DVD201; 
London, Ontario) positioned approximately 1 m from the mirror. 
3.1.3 Vaginal lavage collection 
 Animals were allowed one week to acclimatize before being handled. Following 
handling, the estrous cycle was tracked daily in female subjects, at the same time each 
day. Vaginal lavages were collected with a pipette filled with distilled warm water, and 
samples were placed onto microscope slides for later scoring of the estrous cycle.  
3.1.4 Experimental procedure 
An illustration of the drug injection and behavioral testing schedule is provided in 
Figure 1 A-B. All conditioning and testing was performed during the afternoon light 
phase (between 1200 and 1600 h) of the light-dark cycle, with females being conditioned 
and tested between 1400-1600 h. The two phases of the experiment consisted of a 
Conditioning Phase (4 days, spaced 72 h apart), and one Drug-free Test Day 72 h 
following the final conditioning day. There were 4 groups of male and 4 groups of female 
rats (n = 9 -10/group). Rats of each sex were randomly assigned to 1 of 4 groups (64 
mg/kg LiCl, 96 mg/kg LiCl, 128 mg/kg LiCl, or NaCl control). Since conditioning 
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occurred every 72 h, each female experienced each conditioning day in a different phase 
of the estrous cycle.  
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A 
 
 
 
B 
 
Figure 1 A. Conditioning Procedure. Subjects were treated with either 64, 96, or 128 mg/kg LiCl or NaCl 
(intraperitoneal) and immediately placed into a distinctive context alone for 30 minutes. B. Experimental 
Timeline. There were 4 Conditioning Days, spaced 72 h apart. 72 h following the final Conditioning Day, 
each animal was re-exposed to the distinct context in a drug-free state, and conditioned aversion-related 
disgust behaviors (gaping, paw treading, forelimb flails, head shakes, chin rubs) were recorded and 
analyzed. 
Day         1 2     3     4 5     6     7 8     9     10 11     12     13
Conditioning Phase
Days 1, 4, 7, 10
Drug-free Test Day
Re-exposed to context for 10 minutes
Treatment 
 (intraperitoneal; 0.15M) 
64 mg/kg LiCl 
or 
96 mg/kg LiCl 
 or  
128 mg/kg LiCl 
or 
0.9% NaCl 
Immediate 
exposure to 
 distinct context  
for  
30 minutes 
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3.1.4.1 Conditioning phase 
  On each day of the Conditioning Phase (4 days, 72 h apart), animals were treated 
with an intraperitoneal injection of either 64, 96 or 128 mg/kg lithium chloride (LiCl; 10, 
15, or 20 ml/kg; 0.15M), or with 0.9% isotonic saline (NaCl; 20 ml/kg) as the control (0 
mg LiCl). Each rat was immediately placed into the distinctive context for 30 minutes. 
Following each exposure to the distinctive context, animals were quickly returned to the 
home cage. There were 8 groups in total: NaCl male, 64 mg/kg LiCl male, 96 mg/kg LiCl 
male, 128 mg/kg LiCl male, NaCl female, 64 mg/kg LiCl female, 96 mg/kg female, and 
128 mg/kg LiCl female. An illustration of the group composition is shown in Table 1. 
Prior studies have demonstrated conditioned gaping behavior to be a robust response to a 
distinctive context following a conditioning phase that employed 128 mg/kg LiCl in male 
rats (Chan et al., 2009; Chan et al., 2013; Cloutier et al., 2012b). More variable, but 
significant, conditioned gaping has also been shown following treatment with 32 and 64 
mg/kg LiCl in male rats (Cloutier et al., 2011; Cloutier et al., 2012a; Ossenkopp et al., 
2011). Conditioned gaping following 96 mg/kg LiCl treatment in the anticipatory nausea 
rodent model has not yet been evaluated in males or females. However, a LiCl dose of 96 
mg/kg has been shown to produce a significant conditioned place avoidance in male rats, 
evidenced by significantly less time spent in a previously drug-paired chamber, relative 
to a safe, saline-paired chamber (Tenk et al., 2005).  
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Table 1. Group Designation. Numbers of subjects per treatment group.  
  
LiCl Dose (0.15M) Male n Female n 
0 mg/kg (0.9%NaCl) 10 10 
64 mg/kg 9 9 
96 mg/kg 9 10 
128 mg/kg 9 10 
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3.1.4.2 Drug-free test day 
 72 h following the final Conditioning Day, each animal was re-exposed to the 
distinctive context for 10 minutes in a drug-free state, and behavioral responses were 
video recorded for later scoring.  
3.1.5 Data analysis 
 On the 10 minute drug-free Test Day, dependent variables included conditioned 
gaping behavior, and other aversion-related disgust behaviors, such as, paw treading, chin 
rubs, forelimb flails, and head shakes, as well as, a composite score (cf. Ossenkopp and 
Mazmanian, 1985) of these non-gaping aversion-related behaviors (see Grill and 
Norgren, 1978). Gaping was defined as lowering of the mandible and the pushing or 
thrusting out of the lower teeth (see Parker and Limebeer, 2006). All dependent variables 
were scored blind. 
A 2 x 4 between-subjects analysis of variance (ANOVA) was used to analyze 
each dependent variable. The between-subjects factors were Sex (at 2 levels: male or 
female), and Drug (at 4 levels: 0, 64, 96, or 128 mg/kg LiCl). Linear contrasts were 
performed for each dependent variable in order to analyze sex- and drug-dose response 
effects. As this study was exploratory, all post hoc pairwise comparisons were performed 
using Fisher’s Least Significant Difference (LSD). All statistical tests used a significance 
criterion of α = 0.05. All data presented reflects conditioned responding, while the animal 
was in a completely drug-free state (no injections). Statistical analyses were performed 
using IBM SPSS Statistics 23 for Windows. 
3.2 Results 
 Results demonstrated that all LiCl-treated animals treated with either 128 mg/kg 
or 96 mg/kg LiCl developed significantly stronger conditioned gaping behavior, relative 
to controls. At each of these doses, females further displayed significant gaping 
frequencies relative to LiCl-treated males, indicative of dose- and sex-related effects. 
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3.2.1 Conditioned gaping behavior 
 The between-subjects ANOVA revealed a significant main effects of Sex F(1, 68) 
= 11.862, p< 0.001, and Drug F(3, 68) = 34.997, p< 0.0001, on the expression of gaping 
behavior on the drug-free test day. Furthermore, a significant Sex x Drug interaction was 
obtained, F(3, 68) = 3.107, p< 0.032, as well as, significant sex- and dose-dependent 
increases in gaping behavior, evidenced by significant linear contrasts (p’s< 0.001). 
Means and their Standard Errors (S.E.M.) are depicted in Figure 2. 
 Post hoc pairwise comparisons revealed that females treated with 96 or 128 mg/kg 
LiCl displayed significantly higher frequencies of conditioned gaping behavior, relative 
to males treated with the same doses (p’s< 0.002).  
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Figure 2. Conditioned Gaping Behavior. Mean (+ S.E.M.) frequency of conditioned “gaping” behavior 
expressed by Groups NaCl, 64 mg/kg LiCl, 96 mg/kg LiCl, and 128 mg/kg LiCl (males and females; n = 9-
10/group) during the 10-minute re-exposure to the distinctive context on the Drug-Free Test Day. LiCl-
treated males and females in Groups 96 mg/kg LiCl and 128 mg/kg LiCl displayed significantly higher 
gaping frequencies relative to controls (p’s < 0.05). A dose-related sex difference was also observed with 
females displaying significantly higher gaping frequencies at 96 mg/kg and 128 mg/kg LiCl relative to 
males (p < 0.001 and p < 0.01, respectively). 
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3.2.2 Other conditioned aversion-related disgust 
behaviors (gaping excluded) 
 Conditioned aversion-related behaviors that did not include gaping (i.e., chin rubs, 
paw treads, forelimb flails, and head shakes) were analyzed separately and as a composite 
score. The ANOVA revealed a significant main effect of Drug Treatment for Chin Rubs, 
F(3, 68) = 14.481, p< 0.0001; Forelimb Flails, F(3, 68) = 3.906, p< 0.012; Paw Treads, 
F(3, 68) = 10.145, p< 0.0001; and, the aggregate score, F(3, 68) = 17.878), p< 0.0001. 
No significant main effect of, or interaction with, Sex was found. Significant dose-
dependent increases in the frequencies of Chin Rubs, Forelimb Flails, Paw Treads, and 
the composite score of aversion-related behavior was obtained, evidenced by significant 
linear contrasts (p’s< 0.02). Means and S.E.M are depicted in Figure 3. 
 No significant sex differences were revealed in the post hoc analyses (LSD) for 
conditioned aversion-related behaviors that did not include gaping behavior.
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Figure 3. Composite Score of Disgust Behavior (gaping excluded). Mean (+ S.E.M.) frequency of a total 
aggregate of chin rubs, forelimb flails, paw treads, and chin rubs expressed by Groups NaCl, 64 mg/kg 
LiCl, 96 mg/kg LiCl, and 128 mg/kg LiCl (males and females; n = 9-10/group) during the 10-minute re-
exposure to the distinctive context on the Drug-Free Test Day. LiCl-treated males and females displayed 
dose-related increases in non-gaping disgust behaviors (p’s < 0.05). No significant sex differences were 
found. 
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3.2.3 Cycle tracking 
 Vaginal lavage samples were collected daily and examined under the microscope 
at 10x magnification for cycle phase classification. Results are based on normally cycling 
females, where cycle day was observed to be equally distributed across and within groups 
on the first conditioning day. 
 
3.3 Discussion 
 The current study examined putative sex differences in the formation of 
conditioned disgust behaviors, most notably gaping behavior, in the rodent model of 
anticipatory nausea, using three different doses of the nausea-inducing toxin LiCl (64, 96, 
or 128 mg/kg), and a saline control (0 mg LiCl). It was hypothesized that female rats 
would show greater levels conditioned disgust responses relative to males in a toxin dose-
dependent manner. Our hypothesis was largely supported. Results showed larger dose-
related increases in conditioned gaping behavior in females, relative to males, on the 
drug-free test day. Although LiCl-treated subjects displayed significantly higher 
frequencies of other aversion-related behaviors (i.e., chin rubs, paw treads, and forelimb 
fails), relative to saline-treated subjects, no significant sex effect was observed at any 
drug dose for these behaviors. The current study thus replicated previous evidence of a 
LiCl dose relationship to the level of conditioned gaping (Ossenkopp et al., 2011) . 
Nausea-producing effects can be produced by chemicals acting on the area 
postrema (a chemoreceptor trigger zone for emesis), by activating abdominal vagal and 
glossopharyngeal afferents, as well as with provocative vestibular stimulation (Borison, 
1988; Sanger and Andrews, 2006; Kenwood et al., 2015). Nausea is necessary for the 
establishment of both conditioned taste aversions as well as context conditioned disgust 
response (anticipatory nausea ; see Parker, 2003; Parker et al., 2006; Parker and 
Limebeer, 2006). Typically, nausea-inducing toxins, such as LiCl, are employed in rodent 
conditioned disgust paradigms, but rats have also been shown to condition disgust 
responses with other nausea-inducing treatments, such as provocative vestibular 
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stimulation (Cordick et al., 1999; Ossenkopp et al., 2003), a non-pharmacological 
treatment, and even estradiol injections (Ossenkopp et al., 1996). 
Although the neural mechanisms underlying conditioned nausea learning require 
further examination, it does appear that an intact area postrema is critical for successful 
taste avoidance/aversion learning with LiCl (Eckel and Ossenkopp, 1996; Ossenkopp and 
Eckel, 1994,1995). The chemosensitive area postrema is a circumventricular medullary 
structure implicated in the detection of blood-borne toxins, such as LiCl (Borison, 1989). 
Animals with area postrema lesions will fail to acquire conditioned taste 
avoidances/aversions conditioned with LiCl and other toxins (Eckel and Ossenkopp, 
1996; Ossenkopp and Eckel, 1994,1995; Ossenkopp et al., 1997). The area postrema has 
also been associated with estradiol-induced hypophagia, which is salient to taste-illness 
associations. Markers for neuronal activity, such as c-fos like immunoreactivity (c-FLI), 
are activated in this structure following exogenous administration of estradiol benzoate, 
consistent with the typical time period for estradiol-induced hypophagia (Chambers and 
Hintiryan, 2009). Furthermore, area postrema lesions have been shown to eliminate 
hypophagia expressed by male rats exposed to chronic estradiol treatment (Bernstein et 
al., 1986). The role of area postrema in forming associations between feelings of nausea 
and specific contexts or environments, such as those in anticipatory nausea or 
conditioned place avoidance paradigms, or, how area postrema may be influenced by sex 
hormones in this paradigm, have not been yet examined.  
The continued development of anti-emetic and anti-nausea pharmacotherapies is 
critical, and preclinical animal models can provide a valuable method of testing drugs 
that may attenuate or eliminate nausea in both males and females. The anti-emetic effects 
of 5-hydroxytryptamine3 (5-HT3) and neurokinin1 receptor (NK1) antagonists are well-
documented and help to alleviate nausea and vomiting to some degree, but do not 
attenuate nausea in general, leaving it difficult to treat (Sanger and Andrews, 2006). 5-
HT3 is effective during the acute-phase following cytotoxic drug treatment (Miner and 
Sanger, 1986; Costall et al., 1986), and NK1 helps to attenuate vomiting in the delayed-
phase following chemotherapy treatment, but does not significantly reduce feelings of 
nausea (see Andrews and Rudd, 2004; Sanger and Andrews, 2006). Growing evidence 
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suggests that treatments targeting the endocannabinoid system may help to regulate 
nausea. However, the efficacy of these substances, such as, delta-9-tetrahydrocannabinol 
(THC), canabidiolic acid (CBDA), and fatty acid amide hydrolase (FAAH) inhibitors that 
increase anandamide (an endogenous cannabinoid), has only been evaluated in male 
subjects (see Cross-Mellor et al., 2007; Rock et al., 2015; Sticht et al., 2015b), and future 
research should test these effects in females, given that they show greater conditioned 
nausea responses, relative to males. 
Women report higher incidences of nausea relative to men in anticipatory nausea, 
but apparent sex differences also exist across a wide variety of other nausea-related 
health issues. Gender differences in Motion Sickness Susceptibility (MSS) were assessed 
by self-report questionnaires that measured both MSS (MSSQ) and trait anxiety (STAI-
B) (Paillard et al., 2013). In healthy participants who did not have a history of vestibular 
abnormalities, women were found to have greater motion sickness susceptibility relative 
to men. Trait anxiety in healthy women yielded a small positive correlation with MSS, 
however this was not sufficient to explain the sex difference.  Motion sickness also has 
been shown to fluctuate over the menstrual cycle (Golding et al., 2005). However, sex 
steroids do not fully explain sex differences in MSS, and it has been suggested that 
perhaps females have “hard-wired” differences that leave them more susceptible to 
nausea, relative to their male counterparts (Golding et al., 2005). Female sex is also the 
most relevant predictor of post-operative nausea/vomiting (PONV) in young adulthood 
(Fujii, 2009) and this sex difference in PONV has been shown to persist into late 
adulthood (mean age 73), with elderly women reporting higher incidence and severity of 
PONV relative to men (Conti et al., 2014).  
Sex differences in classically conditioned behaviors have been shown to be 
dependent, in part, on plasma concentrations of sex hormones, such as, estrogen. For 
example, female rodents learn faster in the classical eyeblink conditioning paradigm, 
relative to males, when training begins during proestrus, but this sex difference is 
abolished by ovariectomy (for review see Dalla and Shors, 2009). However, since this 
sex difference is also apparent when training begins in diestrus, a cycle phase associated 
with low estrogen, it suggests a role for progesterone and luteinizing hormone as well 
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(Dalla et al., 2009). Other studies have reported situations in which males consistently 
outperform females, as in contextual fear conditioning (Dalla and Shors, 2009; Pryce et 
al., 1999). Ovariectomy, but not castration, abolished this sex difference, with 
ovariectomized females showing similar levels of freezing responses relative to males 
(e.g., Leuner et al., 2004). 
Future studies should examine a putative role of female sex steroids, such as, 
estrogen and progesterone, in the acquisition of conditioned disgust behavior. By 
considering the phases of the estrous cycle, or performing ovariectomy with or without 
replacement of hormones, the strength and severity of conditioned disgust can be directly 
examined in female rodents. The continued development of anti-emetic and anti-nausea 
pharmacotherapies is of importance and preclinical animal models provide a valuable 
method of testing drugs with the potential to alleviate nausea in both males and females. 
3.3.1 Conclusions 
 It was hypothesized that female rats would condition higher levels of disgust 
responses relative to males, in the rodent model of anticipatory nausea, in a toxin dose 
related manner. It was found that female rats exhibited significantly stronger conditioned 
disgust responding (i.e., gaping) to a context paired with the effects of LiCl treatment at 
the two largest doses, 96 mg/kg and 128 mg/kg. This sex difference was particular to 
conditioned “gaping” behavior, as no significant sex difference was found for any other 
aversion-related disgust behavior (i.e., forelimb flailing, chin rubbing, paw treading, and 
head shaking). The present findings provide further strong support for the rodent model 
of anticipatory nausea and its ability to model, in rodents, the same sex difference 
observed in the human oncology population. 
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Chapter 4 
4 Examining the effects of lipopolysaccharide (LPS) on 
the acquisition of conditioned place avoidance in the 
female rat and the effect of peripubertal endotoxin 
treatment on homotypic challenge in adulthood. 
4.1 Aversive conditioning with LiCl 
The toxin lithium chloride (LiCl) induces vomiting in species with an emetic reflex 
(Borison, 1989), and produces behavioral symptoms consistent with visceral illness in 
non-emetic species, such as rats and mice (Ossenkopp & Eckel, 1995; Parker, 2003). 
LiCl treatment leads to hypophagia (e.g., Curtis et al., 1994), including decreases in 
sodium consumption following sodium depletion (Chavez et al., 1995), and conditioned 
taste + illness associations, such as conditioned taste aversion or conditioned taste 
avoidance (Eckel & Ossenkopp, 1996; Ossenkopp et al., 2003; Parker, 1982; Zalaquett 
and Parker, 1989; Nachman and Ashe, 1973; Nachman, 1970; Parker, 2003). The 
nauseogenic effects of LiCl treatment have also been shown to produce conditioned 
disgust responses in rats re-exposed to distinct contexts that were previously paired with 
the toxin, such as those in the conditioned place aversion and conditioned place 
avoidance paradigms.  
Chemotherapy treatment plays a major role in cancer survival rates; however, its 
cytotoxicity produces undesirable side-effects, including severe acute and delayed 
nausea. Such nausea can lead to the establishment of Anticipatory Nausea (AN). AN 
presents as a classically conditioned phenomenon (Stockhorst et al., 2006; Bovbjerg, 
2006), where the pairing of a novel hospital context with nausea produced by 
chemotherapy leads to the establishment of a robust conditioned nausea/vomiting 
response upon re-entry into the hospital context on subsequent visits, prior to actual drug 
treatment (Morrow et al., 1997; Mollasiotis, 2005). This form of conditioned context 
aversion can be modelled in the rat by pairing LiCl injection with exposure to a distinct 
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contextual chamber. Rats will display Conditioned Disgust Responses upon re-exposure 
to the same context in a drug-free state. Rats lack an emetic reflex, but display a 
“conditioned gaping” behavior that is considered to be an index of nausea/disgust in the 
rat (see Limebeer et al., 2006; Parker et al., 2008).  
Related to the rodent model of AN is the Conditioned Place Avoidance (CPA) 
paradigm. The two-chamber CPA paradigm involves the pairing of a drug treatment (e.g., 
LiCl) with one of two distinct chambers, and pairing saline control injections with the 
other, contextually distinct, chamber ( see Frisch et al., 1995, Miller et al., 2000, Parker, 
1992, Turenne et al., 1996 and White and Carr, 1985). Drug-paired and saline-paired 
exposures alternate over two consecutive conditioning cycles. On a drug-free test day 
(i.e., extinction phase), rats will spend significantly less time in a chamber previously 
paired with LiCl effects, relative to time spent in the saline-paired (i.e., “safe”) chamber. 
Indeed, this effect has been demonstrated across a variety of LiCl doses ranging from 20 
mg/kg to 128 mg/kg (Khroyan et al., 1995; Miller et al., 2000; Parker & McDonald, 
2000; Tenk et al., 2005; Turenne et al., 1996; White & Carr, 1985), but not at lower doses 
of LiCl, such as, 10 mg/kg (Miller et al., 1999, 2000). LiCl has been shown to produce 
dose-dependent decreases in locomotor behavior during the conditioning phase (see Tenk 
et al., 2005). During the drug-free extinction phase, subjects that were treated with LiCl 
during conditioning spent significantly less time in the previously drug-paired chamber 
relative to controls. However, this drug effect was not dose-dependent (Tenk et al., 2005). 
Higher doses of LiCl (128 mg/kg and 96 mg/kg) produced significant dose-dependent 
increases in the frequency of aversion-related vertical movements, such as rearing 
behavior, in the formerly drug-paired chamber, relative to a lower dose of 32 mg/kg LiCl 
(Tenk et al., 2005). However, thus far, LiCl effects on place avoidance conditioning have 
only been evaluated in males. 
4.2 Immune system stimulation and learning 
The endotoxin lipopolysaccharide (LPS) is the active component of the cell wall 
of Gram-negative bacteria, and when injected into an animal, results in the production of 
pro-inflammatory cytokines (Dinarello, 1984) that initiate a specific set of 
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pathophysiological and behavioral changes collectively known as “sickness behaviors”. 
These “sickness behaviors” include induction of fever (Hart, 1988; O’Reilly, Vander, & 
Kluger, 1988; Roth et al., 1997), anorexia and adipsia (Cross-Mellor et al., 2000; Gayle et 
al., 1998; Langhans, 2000; Langhans et al., 1990), reductions in locomotor activity (Hart, 
1988; Engeland et al., 2003a; Franklin et al., 2003; Yirmiya et al., 1994), hypersomnia 
(Hart, 1988), and reduction in grooming (Hart, 1988), helping the organism counter the 
effects of the bacterial infection (Hart, 1988).  
Significant learning and memory impairments have been observed following LPS 
treatment in Contextual Fear Conditioning and Two-Way Active Avoidance paradigms 
(e.g., Pugh et al., 1998; Kranjac et al., 2012; Sparkman et al., 2005), as well as, in animal 
models of conditioned disgust such as Conditioned Taste Aversion (Cross-Mellor et al., 
2009) and the rodent model of Anticipatory Nausea (AN; Chan et al., 2009; Chan et al., 
2013; Cloutier et al., 2012 a,b; Cloutier et al., 2016 b). Male rats pre-treated with LPS 90 
minutes prior to LiCl + taste pairings failed to acquire significant conditioned active and 
passive aversion responses (e.g., gaping, forelimb flailing, chin rubbing, head shaking, 
paw treading, and passive drip) when involuntarily infused with the taste in the absence 
of drug treatment, relative to saline controls, in the Taste Reactivity Test (TRT) for 
conditioned taste aversion (CTA) (see Grill & Norgren, 1978 a,b; Cross-Mellor et al., 
2009). LPS, however, failed to block taste avoidance learning, actually inducing 
significant reductions in sucrose consumption in a 2-bottle voluntary intake test for 
conditioned taste avoidance (Cross-Mellor et al., 2004).  
It is important to highlight that in order to produce true conditioned taste aversion, 
a nauseogenic unconditioned stimulus is required. Evidence supports the fact that 
conditioned taste aversion and conditioned taste avoidance may represent two distinct 
processes (see Chambers, 2015; see Parker, 2003) and this may provide a basis for the 
differential effects of LPS on the acquisition of the two the conditioned behaviors. 
Similar to what has been demonstrated with the development of CTA, LPS pre-treatment 
90 minutes prior to LiCl + context pairings blocks the acquisition and expression of 
conditioned context aversion (i.e., disgust behavior). LPS treatment in male rats has 
repeatedly been shown to significantly attenuate conditioned “gaping” behavior, as well 
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as, chin rubbing and paw treading, relative to saline controls (Chan et al., 2009; Cloutier 
et al., 2012 a,b; Cloutier et al., 2016 b), even when rats were LPS-tolerant prior to LiCl-
conditioning (Chan et al., 2013). The deleterious effect of LPS on context aversion 
learning has also been demonstrated in female rats (see Cloutier et al., 2016a), which 
conditioned stronger dose-dependent disgust responses, relative to males (Cloutier et al., 
2016 a,b). 
Thus, LPS has been shown to block the acquisition of conditioned taste and 
context aversions, but not conditioned taste avoidance learning (Cross-Mellor et al., 
2004). However, LPS has been shown to block the simultaneous establishment of 
conditioned context aversion and taste avoidance following the delivery of an 
intravascular saccharin taste mixed with LiCl treatment, immediately prior to exposure to 
a distinct context (Cloutier et al., 2012 a). Although, it should be noted that intravascular 
administration of a tastant may conditioned weaker responses, relative to oral 
presentation of the Conditioning Stimulus, as it relies on transport through the blood 
(Fishberg et al., 1933). To date, the putative deleterious effects of LPS pre-treatment 
during LiCl-induced Conditioned Place Avoidance conditioning has not yet been 
evaluated in males or females. 
4.3 Lipopolysaccharide and conditioned place avoidance 
learning 
 The current study examined LiCl-induced conditioned place avoidance (CPA) 
learning in adult Long-Evans female rats, using a dose of 96 mg/kg, which was 
previously shown to establish robust conditioned avoidant responding in male rats of the 
same strain, in the same 2-chamber CPA apparatus (Tenk et al., 2005). This study further 
examined the effects of LPS pre-treatment during conditioning on the expression of CPA 
behavior on a drug-free test day. It was hypothesized that 96 mg/kg LiCl-treated female 
rats would establish robust CPA learning; and, that pre-treatment with LPS would 
significantly attenuate learning in this paradigm, similar to what was observed in the 
rodent model of anticipatory nausea (e.g., Chan et al., 2009; Cloutier et al., 2011; 
Cloutier et al., 2016 a,b).  
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Puberty represents a period during which sexual maturity is achieved (Schulz and 
Sisk, 2006), and is accompanied by numerous physiological changes and significant brain 
reorganization (Shulz et al., 2009). Systemic LPS treatments administered during 
sensitive periods of development (i.e., neonatal and peripubertal periods) have been 
shown to produce long-term alterations in behavior. For example, LPS-treated neonatal 
male rat pups displayed exacerbated acute-phase responses to a second LPS challenge in 
adulthood, relative to saline controls, while females in the same treatment group did not 
(Tenk et al., 2008). Female mice injected with LPS during the peripubertal phase (6 
weeks old), displayed long-term alterations in behavior, such that estrogen became 
anxiogenic, as opposed to producing its typically anxiolytic effects (Blaustein et al., 
2011). Furthermore, it was shown that, in female mice, an LPS challenge at 6 weeks of 
age prevented estradiol-enhanced cognition in adulthood in social and object recognition 
paradigms (Blaustein et al., 2013).  
In the current study, the influence of peripubertal (6 weeks old) LPS challenge in 
female rats on the development of CPA behavior, and on the response to a homotypic 
drug challenge in adulthood, were examined. It was hypothesized that an LPS challenge 
during puberty might alter CPA learning in adulthood, relative to females treated with 
saline at 6 weeks. It was hypothesized that LPS challenges in both adolescence and 
adulthood would alter CPA learning, as well as, the response to the endotoxin treatments. 
 
4.4 Materials and Methods 
4.4.1 Subjects 
Subjects were 62 naïve female Long-Evans rats (Charles River, Canada) weighing 
between 150 and 200 g at the start of the experiment. Rats arrived in the laboratory two 
weeks prior to the commencement of the experimental manipulations. Animals were 
given one week to acclimatize and at least 3 separate handling sessions prior to the 
beginning of the experiment. The rats were housed in pairs in standard polypropylene 
cages (45 x 22 x 20 cm) in a temperature-controlled colony room (20 ± 1 °C) maintained 
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on a 12: 12 h light: dark cycle (lights on at 07:00) with ad libitum access to both food 
(ProLab rat chow) and tap water. All testing took place during the light phase of the light: 
dark cycle. All procedures were approved by the University of Western Ontario Animal 
Care Committee and were in accordance with the Canadian Council of Animal Care 
(CCAC) guidelines. 
4.4.2 Drugs 
Lithium Chloride (LiCl) was dissolved in distilled water to a molarity of 0.15M 
and given at a dose of 96 mg/kg. Isotonic saline (NaCl; 0.9%, 0.15M) was employed as 
the control injection. Lipopolysaccharide (LPS; derived from E. coli serotype 0111: B4, 
no. L-2630; Sigma) was dissolved in pyrogen-free 0.9% isotonic saline, and was 
administered at a dosage of 200 µg/kg (1 mL/kg). Doses were based on those employed 
in previous studies showing a physiological effect of the drug (e.g., Engeland, Kavaliers, 
& Ossenkopp, 2003). All injections were administered intraperitoneally. 
4.4.3 Apparatus 
The two-chamber place-conditioning apparatus consisted of eight modified 
Versamax Animal Activity Monitors (Accuscan Model RXYZCM-16, Columbus, OH). 
Each monitor consisted of a clear Plexiglas open-field (40 x 40 x 30.5 cm) covered by a 
Plexiglas lid with air holes. Infrared photobeams were located 2.54 cm apart and 5.7 cm 
above the floor along the perimeter of the box (16 beams per side). Two additional banks 
of 16 photobeams were located on opposite sides of the box, 2.54 cm apart and 16.4 cm 
above the floor. Beam breaks in lower and upper banks correspond to movements in the 
horizontal and vertical planes, respectively (Ossenkopp & Kavaliers, 1996). All activity 
monitors were connected to a Versamax data analyzer (Accuscan Model DCM-8, 
Columbus, OH), which then transmitted data to the computer for further analysis. 
Locomotor activity and its distribution within the two chambers were quantified using the 
Versamax Software System (Version 2.60, Accuscan, Columbus, OH). 
Each Animal Activity Monitor was divided into two equal sized chambers (20 x 
40 x 30.5 cm) by a clear Plexiglas partition located parallel to the elevated photobeams so 
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as not to interrupt theses sensors. The two chambers differed in visual wall cues and 
tactile floor cues. One chamber contained a removable wire mesh floor while the other 
chamber contained a removable clear, rough Perspex floor. The outside wall of each 
chamber displayed either a solid gray or black (1.8 cm) and white (2 cm) striped pattern. 
During conditioning trials, a solid Plexiglas partition confined the animal to one chamber 
and the walls of both chambers displayed the same visual pattern.  
During the extinction trial, a Plexiglas partition with a doorway (10 × 15 cm) 
allowed passage between the chambers with each chamber displaying one of the wall 
patterns. During both conditioning and extinction, the gray wall pattern was paired with 
the rough-textured floor and the black and white striped wall pattern was paired with the 
wire mesh floor. Average illumination in the rough floor-gray wall chamber was 1065.5 
± 209.6 lx (measured with Digital Illuminometer, Mitchell Instruments Model YF-1065F, 
San Marcos, CA) and average illumination in the smooth floor-striped wall chamber was 
1084.0 ± 214.2 lx. 
The place preference and activity variables were quantified directly by the 
Versamax analyzer for each of the two chambers. The place preference measure was 
Time (s) spent in each chamber during extinction trials. Horizontal activity measures 
included Total Horizontal Distance (cm), Horizontal Movement Time (s), and Number of 
Horizontal Movements. Vertical activity measures included Vertical Time (s) and 
Number of Vertical Movements. 
4.4.4 Procedure 
4.4.4.1 Peripubertal Immune Challenge 
At 6 weeks of age, all subjects were injected (intraperitoneal) with either 200 
µg/kg LPS or 0.9% isotonic NaCl (1 mL/kg), and returned to the home cage. Body 
weight was measured prior to injection and 24 h following treatment. Vaginal lavage 
samples were collected the day of and 24 h following treatment. 
4.4.4.2 Conditioning phase 
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Subjects received two conditioning cycles, each consisting of four, 30 min 
conditioning trials. Conditioning trials were 30 min in length because LiCl exerts 
maximal effects on behaviour 15–30 min following administration (e.g., Parker et al., 
1984). The conditioning trials were separated by 24 h and alternated between drug and 
saline trials. Thus, each conditioning cycle was comprised of two drug and two saline 
trials. The two conditioning cycles were separated by 72 h. Prior to conditioning trials, 
animals were weighed and pre-treated with LPS or NaCl. 90 minutes later, following 
administration of LiCl or saline, animals were quickly placed in the apparatus. Each 
apparatus and all removable floors were cleansed with a mild detergent solution and 
rinsed with a baking soda solution after each conditioning and extinction trial. 
On odd-numbered conditioning trials (Trials 1, 3, 5, 7; Days 1, 3, 7, and 9), 
different groups of rats received intraperitoneal injections of either 200 µg/kg LPS or 
0.9% NaCl, followed 90 minutes later by an injection of 95 mg/kg LiCl or 0.9% NaCl, 
and were then confined to the right chamber for 30 min. Drug-paired chambers were 
counter-balanced so that half consisted of the striped wall-wire mesh floor pairing, and 
the other half consisted of the gray wall-rough floor pairing. On even-numbered 
conditioning trials (Trials 2, 4, 6, 8; Days 2, 4, 8, and 10), rats received control pre-
treatment injections of 0.9% 0.15 M NaCl in the same volume as the LPS injection, 
followed 90 minutes later by a second injection of 0.9% NaCl equal to that of LiCl, and 
were confined to the left chamber for 30 min, with respective counter-balancing of 
chamber patterns and flooring. A procedural schedule is given in Figure 1. Locomotor 
activity was measured during each of the conditioning trials. Body weight was measured 
on each conditioning day and 24 h following each conditioning day. During the entire 
conditioning period, vaginal lavage samples were collected each day. 
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Phase
6 weeks old
Conditioning
NaCl NaCl NaCl NaClLiCl LiCl LiCl LiCl
LPS LPS
0.9 %
NaCl
200 µg/kg 
LPS
NaCl NaCl90 min prior
Immediate
Phase
6 weeks old
Conditioning
NaCl NaCl NaCl NaClNaCl NaCl NaCl NaCl
NaCl NaCl
0.9 %
NaCl
200 µg/kg 
LPS
NaCl NaCl90 min prior
Immediate
Procedure
1          2         3         4        5      6         7         8         9         10      11    12 
Cycle 1 Cycle 2
Drug-Paired
Right 
Chamber Only
NaCl-Paired
Left 
Chamber Only
20 min. DRUG-FREE Test Day
Figure 1. Injection schedule and procedure. 
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4.4.4.3 Drug-free test day 
Seventy-two hours following the last conditioning trial, rats received one, 20 min 
test trial. The test trial was 20 min in length to minimize the effects of habituation on 
locomotor activity which tends to occur after 20 min (Engeland et al., 2003). Rats 
received no injections prior to the extinction trials. The animals were initially placed in 
the centre of the chamber previously paired with LiCl and allowed unrestricted access to 
both chambers. Locomotor activity and the spatial distribution of behaviour were 
assessed in each chamber. 
4.4.5 Statistical analyses 
4.4.5.1 Six-week-old (peripubertal) treatment  
 Following LPS treatment, significant reductions in body weight are typically 
observed 24 h post-treatment, relative to controls (e.g., Engeland et al., 2003). Percent of 
body weight change was calculated by subtracting the Conditioning Day body weight 
from the 24 h post-treatment weight, then dividing by the Conditioning Day body weight 
and multiplying by 100. 
 A one-way between-subjects Analysis of Variance (ANOVA) was used to analyze 
percent changes in body weight 24 h after the peripubertal (6 weeks), with one factor of 
Drug 1 (at two levels: LPS or NaCl). All statistical analyses used a significance criterion 
of α = 0.05. 
4.4.5.2 Conditioning Phase 
 Dependent variables examined during the Conditioning Phase included: percent 
changes in body weight (as calculated above), Total Distance Travelled (cm), Horizontal 
Movement Time (s), Vertical Movement Time (s), and Number of Vertical Movements. 
This set of variables was examined on both Drug-paired (days 1, 3, 7, 9) and NaCl-paired 
(days 2, 4, 8, 10) conditioning days. Body weight was analyzed for Drug-paired days and 
NaCl-paired days separately, in two Mixed Design Repeated Measures ANOVAs. The 
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within-subjects factor was Day ( at 4 levels: Drug-paired Days 1, 3, 7, 9; or, NaCl-paired 
Days 2, 4, 8, 10), and 3 between-subjects factors consisting of Drug 1 (at 2 levels: 
peripubertal LPS or NaCl), Drug 2 (at 2 levels: adult LPS or NaCl), and, Drug 3 (at 2 
levels: NaCl or LiCl). Each remaining dependent variable was analayzed using a 2 x 2 x 
2 Between-subjects ANOVA, with 3 between-subjects factors consisting of Drug 1 (at 2 
levels: peripubertal LPS or NaCl), Drug 2 (at 2 levels: adult LPS or NaCl), and, Drug 3 
(at 2 levels: NaCl or LiCl).  
 Since this study was exploratory, all post hoc pairwise comparisons were 
performed using Fisher’s Least Significant Difference (LSD), except for changes in body 
weight, which are well-documented, and thus examined with the more conservative 
Tukey’s Honestly Significant Difference (HSD) post hoc test. All statistical tests used a 
significance criterion of α = 0.05. All analyses were run in IBM SPSS 20.0 for Windows. 
4.4.5.3 Drug-free Test Day 
 On a drug-free Test Day, each animal was reintroduced into the drug-paired 
chamber, but this time allowed to escape into the previously NaCl-paired chamber (i.e., 
the “safe” chamber) through an opening in the wall dividing the two chambers of the 
apparatus. Since subjects spend different amounts of time in each chamber, dependent 
variables (excluding Duration) were corrected to reflect the frequency of behavior per 
minute spent in a given chamber. Dependent variables measured on the Extinction Day 
included: Duration (min), Total Distance Travelled (cm/min), Horizontal Movement 
Time (s/min), Vertical Movement Time (s/min), Number of Vertical Movements 
(movements/min). Each variable was analyzed using a 2 x 2 x 2 x 2 Mixed Design 
Repeated Measures ANOVA, with a within-subjects variable of Chamber (at 2 levels: 
previously Drug-paired or NaCl-paired); and, three between-subjects factors of Drug 1 (at 
2 levels: peripubertal LPS or NaCl), Drug 2 (at 2 levels: adult LPS or NaCl), and, Drug 3 
(at 2 levels: NaCl or LiCl). All post hoc pairwise comparisons were performed using 
Fisher’s Least Significant Difference (LSD).  
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All statistical tests used a significance criterion of α = 0.05. All analyses were run 
in IBM SPSS 20.0 for Windows. 
 
4.5 Results 
 Results demonstrated robust conditioned place avoidance learning in female rats. 
Furthermore, LPS pre-treatment block the formation of CPA. However, in those subjects 
treated with LPS during the peripubertal period and adulthood, tolerance-like effects to 
the acute-phase response, as well as, the previously observed deficit in learning and 
memory, were observed.  
4.5.1 Peripubertal percent change in body weight 
 The one-way ANOVA revealed a significant main effect of Drug 1 (LPS or 
NaCl), F(1, 60) = 100.88, p < 0.0001), where LPS-treated females lost significantly more 
body weight, relative to NaCl-treated females, 24 h following the peripubertal immune 
challenge. Means and their standard errors (S.E.M.) are depicted in Figure 2.  
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Figure 2. Peripubertal Percent Change in Body Weight. Means and their standard 
errors (S.E.M.) for percent of body weight change. The one-way ANOVA revealed a 
significant main effect of Drug 1 (LPS or NaCl), F(1, 60) = 100.88, p < 0.0001), where 
LPS-treated females lost significantly more body weight, relative to NaCl-treated 
females, 24 h following the peripubertal immune challenge.  
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4.5.2 Adult conditioning phase body weight 
4.5.2.1 Drug-paired days 
 24 h percent changes in body weight following each Drug-paired Day or NaCl-
paired Day were analyzed with a mixed factor repeated measures analysis of variance 
(ANOVA). The ANOVA revealed significant main effects of Day (days 1, 3, 7, and 9), 
F(1, 125) = 20.258, p< 0.0001; Drug 1 (pubertal LPS or NaCl), F(1, 54) = 9.102, p< 0.01; 
Drug 2 (adult LPS or NaCl), F(1, 54) = 41.279, p< 0.0001; and, Drug 3 (LiCl or NaCl), 
F(1, 54) = 6.738, p< 0.02. Significant interactions were observed between Day x Drug 1 
(pubertal LPS or NaCl), F(1, 125) = 7.897, p< 0.0001; Day x Drug 2 (adult LPS or 
NaCl), F(1, 125) = 38.402, p< 0.0001; Day x Drug 1 x Drug 2, F(1, 125) = 11.622, p< 
0.0001; and, Drug 1 x Drug 2, F(1, 54) = 7.641, p< 0.01.  
Post hoc pairwise comparisons (Tukey’s HSD) showed that subjects treated with 
LPS during conditioning in adulthood-only (Groups NaCl-LPS-NaCl and NaCl-LPS-
NaCl) lost significantly more body weight following the initial treatment relative to all 
other groups (p’s< 0.01). Females treated with LPS at both time points (Groups LPS-
LPS-NaCl and LPS-LPS-LiCl) showed changes in body weight that were not 
significantly different from non-LPS-treated controls, except Group LPS-LPS-NaCl, 
which showed significantly greater body weight losses after Day 1, relative to Groups 
LPS-NaCl-LiCl and NaCl-NaCl-LiCl (p’s < 0.05), where LiCl-treated animals showed 
minor but greater gains in weight following treatment. Means and S.E.M are depicted in 
Figure 3 A-D. 
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Figure 3 A-D. Adulthood percent change in body weight. A mixed 
factor repeated measures ANOVA revealed a significant Day x Drug 1 
(6 wk LPS or NaCl) x Drug 2 (adult LPS or NaCl) interaction, F(1, 
54) = 7.641, p < 0.01. Following Day 1, adult LPS-treated rats showed 
significant body weight loss (anorexia) relative to NaCl-treated rats, 
but there were no significant differences when rats were treated with 
LPS in both adolescence and adulthood (tolerance). 
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4.5.2.2 Saline-paired days 
 The ANOVA revealed significant main effects of Day (days 2, 4, 8, and 10), F(3, 
123) = 53.087, p< 0.001; and, Drug 2 (adult LPS or NaCl), F(1, 54) = 18.759, p< 0.001. 
Significant interactions were observed between Day x Drug 2, F(3, 123) = 3.213, p< 
0.05; and, Day x Drug 1 (pubertal LPS or NaCl) x Drug 2, F(1, 54) = 3.029, p< 0.05. No 
significant pairwise comparisons were obtained following any of the saline-paired 
treatment days (Tukey’s HSD). 
4.5.3 Adult conditioning phase locomotor behavior 
 During conditioning, the following variables were recorded and analyzed 
separately for drug- and saline-paired days: Total Distance Travelled (cm), Horizontal 
Movement Time (s), Number of Vertical Movements, and Vertical Movement Time (s). 
Each variable was analyzed using a mixed design repeated-measures ANOVA. 
 4.5.3.1 Total Distance Travelled (cm) 
  4.5.3.1.1 Drug-paired days 
 The ANOVA revealed significant main effects of Day (days 1, 3, 7, and 9), F(3, 
162) = 11.616, p< 0.0001; and, Drug 2 (adult LPS or NaCl), F(1, 54) = 27.421, p< 
0.0001. Significant interactions were found between Day x Drug 2, F(3, 162) = 3.00, p < 
0.05; and, Day x Drug 3 (LiCl or NaCl), F(3, 162) = 12.74, p< 0.0001. Means and S.E.M 
are depicted in Figure 4 A-D.  
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Figure 4 A-D. Total Distance Travelled (cm/s). Rats treated with LPS in adulthood-only 
displayed significant decreases in locomotor activity at the beginning of conditioning 
(relative to controls) that were not as robust as those observed in rats treated with LPS both 
in adolescence and adulthood. Towards the end of conditioning, LiCl-treated rats show 
significantly further distances travelled (aversive behaviour) relative to NaCl controls and 
LPS-pretreated rats (adulthood only). Rats pre-treated with LPS in both adolescence and 
adulthood did not differ significantly from other LiCl-treated groups that were not treated 
with LPS (p’s< 0.05), evidence of tolerance to adult homotypic LPS challenge.  
 
96 
 
 
 
4.5.3.1.2 Saline-paired days 
 The ANOVA revealed a significant main effect of Day (days 2, 4, 8, and 10), F(3, 
162) = 3.738, p< 0.05, as well as, significant interactions between Day x Drug 2 (adult 
LPS or NaCl), F(3, 162) = 7.788, p< 0.001; Day x Drug 3 (LiCl or NaCl), F(3, 162) = 
6.661, p< 0.001; Day x Drug 1 (pubertal LPS or NaCl) x Drug 2 x Drug 3, F(3, 162) = 
3.337, p< 0.05; and Drug 1 x Drug 2, F(1, 54) = 4.255, p< 0.05.  
4.5.3.2 Horizontal Movement Time (s) 
  4.5.3.2.1 Drug-paired days 
 The ANOVA revealed significant main effects of Day (days 1, 3, 7, and 9), F(3, 
162) = 14.379, p< 0.0001; and, Drug 2 (adult LPS or NaCl), F(1, 54) = 21.800, p< 
0.0001. Significant interactions were found between Day x Drug 2, F(3, 162) = 3.32, p< 
0.05; and, Day x Drug 3 (LiCl or NaCl), F(3, 162) = 10.512, p< 0.0001.  
  4.5.3.2.2 Saline-paired days 
 The ANOVA revealed a significant main effect of Day (days 2, 4, 8, and 10), F(3, 
162) = 9.412, p< 0.0001. Significant interactions were found between Day x Drug 2 
(adult LPS or NaCl), F(3, 162) = 7.498, p< 0.0001; and, Day x Drug 3 (LiCl or NaCl) 
F(3, 162) = 4.302, p< 0.01. 
4.5.3.3 Post hoc pairwise comparisons (Fisher’s LSD): 
horizontal activity 
 Rats treated with LPS in adulthood-only displayed significant decreases in 
locomotor activity at the beginning of conditioning (relative to controls) that were not as 
robust as those observed in rats treated with LPS both in adolescence and adulthood. 
Towards the end of conditioning, LiCl-treated rats show significantly further distances 
travelled (aversive behaviour) relative to NaCl controls and LPS-pretreated rats 
(adulthood only). Rats pre-treated with LPS in both adolescence and adulthood did not 
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differ significantly from other LiCl-treated groups that were not treated with LPS, 
evidence of tolerance to adult homotypic LPS challenge. Means and S.E.M are depicted 
in Figure 5 A-D. 
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Figure 5 A-D. Horizontal Time (sec/min). Rats treated with LPS in adulthood-only 
displayed significant decreases in locomotor activity at the beginning of conditioning 
(relative to controls) that were not as robust as those observed in rats treated with 
LPS both in adolescence and adulthood. Towards the end of conditioning, LiCl-
treated rats spend significantly more time moving horizontally (indicative of 
agitation) relative to NaCl controls and LPS-pretreated rats (adulthood only). Rats 
pre-treated with LPS in both adolescence and adulthood did not differ significantly 
from other LiCl-treated groups that were not treated with LPS (p’s< 0.05), evidence 
of tolerance to adult homotypic LPS challenge. 
99 
 
 
 
4.5.3.4 Number of Vertical Movements 
 4.5.3.4.1 Drug-paired days 
 The ANOVA revealed significant main effects of Day (days 1, 3, 7, and 9), F(3, 
162) = 8.952, p< 0.0001; Drug 2 (adult LPS or NaCl), F(1, 54) = 32.573, p< 0.0001; and, 
Drug 3 (LiCl or NaCl), F(1, 54) = 7.75, p< 0.01. Significant interactions were found 
between Day x Drug 3, F(3, 162) = 25.204, p< 0.0001, Day x Drug 2 x Drug 3, F(3, 162) 
= 3.729, p< 0.05; and, Drug 2 x Drug 3, F(1, 54) = 8.768, p< 0.01. Means and S.E.M are 
depicted in Figure 6 A-D.        
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Figure 6 A-D. Number of Vertical Movements. Means and S.E.M for number of vertical movements displayed 
during the conditioning phase. Rats treated with LPS in adulthood-only displayed significantly less rearing 
behaviour (aversive behaviour) at the beginning of conditioning (relative to controls) that was not as robust as that 
observed in rats treated with LPS in both adolescence and adulthood. Towards the end of conditioning, LiCl-
treated rats exhibited significantly more rearing behaviour relative to NaCl controls and LPS-pretreated rats.  Rats 
treated with LPS in adolescence and adulthood, although they did not display significant tolerance-like effects to 
the deleterious effects of LPS on conditioning, they displayed trending increases in rearing behaviour over the 
course of conditioning that were significant on the drug-free test day. 
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4.5.3.4.2 Saline-paired days 
 The ANOVA revealed a significant main effect of Drug 1 (pubertal LPS or NaCl), 
F(1, 54) = 6.054, p< 0.05. Significant interactions were found between Day (days 2, 4, 8, 
and 10) x Drug 2 (adult LPS or NaCl), F(3, 162) = 3.056, p< 0.05; and, Day x Drug 3 
(LiCl or NaCl), F(3, 162) = 5.353, p< 0.01.  
 4.5.3.5 Vertical Movement Time (s) 
  4.5.3.5.1 Drug-paired days 
 The ANOVA revealed significant main effect of Day (days 1, 3, 7, and 9), F(3, 
162) = 4.237, p< 0.05. No further significant main effects or interactions were observed.  
 4.5.3.5.2 Saline-paired days 
 The ANOVA revealed a significant main effect of Day (days 2, 4, 8, and 10), F(3, 
162) = 6.405, p< 0.05. No further significant main effects or interactions were observed. 
4.5.3.5.3 Post Hoc Pairwise Comparisons (Fisher’s 
LSD): vertical activity 
 Rats treated with LPS in adulthood-only displayed significantly less rearing 
behaviour (aversive behaviour) at the beginning of conditioning (relative to controls) that 
was not as robust as that observed in rats treated with LPS in both adolescence and 
adulthood. Towards the end of conditioning, LiCl-treated rats exhibited significantly 
more rearing behaviour relative to NaCl controls and LPS-pretreated rats. Rats treated 
with LPS in adolescence and adulthood, although they did not display significant 
tolerance-like effects to the deleterious effects of LPS on conditioning, they displayed 
trending increases in rearing behaviour over the course of conditioning that were 
significant on the drug-free test day (p’s < 0.05). 
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4.5.4 Drug-free Test Day 
 On a drug-free Test Day, each subject was re-exposed to the context in the 
absence of any drug treatment, but this time allowed to move between the two previously 
drug- or saline-paired chambers through an opening in the dividing wall. Each variable 
(excluding Duration) was corrected for frequency of behavior per amount of time spent in 
a given chamber, analyzed using a 2 x 2 x 2 x 2 mixed design repeated measures 
ANOVA. 
4.5.4.1 Duration (min) 
 The ANOVA revealed a significant main effect of Chamber (drug-paired or 
saline-paired), F(1, 54) = 26.156, p< 0.0001 on the duration spent in the drug-paired 
chamber. Significant interactions were also observed between Chamber x Drug 3 (LiCl or 
NaCl), F(1, 54) = 54.619, p< 0.0001; Chamber x Drug 1 (pubertal LPS or NaCl) x Drug 2 
(adult LPS or NaCl), F(1, 54) = 13.043, p< 0.001; and, Chamber x Drug 2 x Drug 3, F(1, 
54) = 4.545, p< 0.05.  
Post hoc pairwise comparisons (Fisher’s LSD) showed that subjects in Groups 
NaCl-NaCl-LiCl, LPS-NaCl-LiCl, and LPS-LPS-LiCl spent significantly less time in the 
previously drug-paired chamber relative to rats treated with NaCl during conditioning, as 
well as, rats pre-treated with LPS prior to LiCl treatment (Group NaCl-LPS-LiCl), p’s< 
0.05. Group NaCl-LPS-LiCl spent significantly less time in the previously drug-paired 
chamber, relative to Groups LPS-NaCl-NaCl and NaCl-LPS-NaCl (p’s< 0.01), but did 
not differ significantly from other controls groups (Groups NaCl-NaCl-NaCl and LPS-
LPS-NaCl). Means and S.E.M are depicted in Figure 7.  
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Figure 7. Duration in drug-paired chamber. Means and S.E.M for duration spent in 
LiCl-paired chamber. LiCl-treated rats spent significantly less time in the Drug-paired 
chamber relative to NaCl controls. Rats pre-treated with LPS (adulthood only) followed 
by LiCl did not differ significantly from controls. Rats treated with LPS in both 
adolescence and adulthood did not show this effect (p’s< 0.05) 
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4.5.4.2 Total Distance Travelled (cm/min) 
 The ANOVA revealed a significant main effects of Chamber (drug-paired or 
saline-paired), F(1, 54) = 28.837, p< 0.0001; and, Drug 3 (LiCl or NaCl), F(1, 54) = 
10.318, p< 0.01. Significant interactions were found between Chamber x Drug 3, F(1, 54) 
= 58.136, p< 0.0001; Chamber x Drug 1 (pubertal LPS or NaCl) x Drug 2 (adult LPS or 
NaCl), F(1, 54) = 12.285, p< 0.001; Chamber x Drug 2 x Drug 3, F(1, 54) = 4.625, p< 
0.05; Drug 2 x Drug 3, F(1, 54) = 5.110, p< 0.05; and, Drug 1 x Drug 2 x Drug 3, F(1, 
54) = 4.091, p< 0.05. 
 Post hoc pairwise comparisons (LSD) showed that subjects in Groups NaCl-
NaCl-LiCl, LPS-NaCl-LiCl, and LPS-LPS-LiCl travelled significantly further in the 
previously drug-paired chamber, relative to all other groups (p’s< 0.01). Rats pre-treated 
with LPS during LiCl conditioning (Group NaCl-LPS-LiCl) travelled a significantly 
shorter distance in the previously drug-paired chamber, relative to all other LiCl-treated 
groups (p’s< 0.01), and did not differ significantly from NaCl controls.  
In the previously saline-paired chamber, females in Groups NaCl-LPS-NaCl and LPS-
NaCl-NaCl travelled significantly further, relative to all other groups (p’s< 0.05), except 
that Group LPS-NaCl-NaCl also travelled significantly further relative to Group NaCl-
NaCl-NaCl (p< 0.05). Means and S.E.M are depicted in Figure 8. 
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Figure 8. Means and S.E.M. Total Distance Traveled on test day (cm/min). 
LiCl-treated rats travelled significantly further in the Drug (LiCl)-Paired chamber 
relative to NaCl controls, unless rats were pre-treated with LPS (adulthood only) 
90 minutes prior to conditioning (p’s < .05). Rats treated with LPS in adolescence 
and adulthood did not show this effect (p’s< 0.05) 
A 
B 
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4.5.4.3 Horizontal Movement Time (s/min) 
The ANOVA revealed significant main effects of Chamber (drug-paired or saline-
paired), F(1, 54) = 31.310, p< 0.0001; Drug 2 (adult LPS or NaCl), F(1, 54) = 4.563, p< 
0.05; and, Drug 3 (LiCl or NaCl), F(1, 54) = 13.571, p< 0.001. Significant interactions 
were found between Chamber x Drug 3, F(1, 54) = 60.860, p< 0.0001; Chamber x Drug 1 
(pubertal LPS or NaCl) x Drug 2, F(1, 54) = 15.433, p< 0.0001; Chamber x Drug 2 x 
Drug 3, F(1, 54) = 5.917, p< 0.05; Drug 2 x Drug 3 = 4.548, p< 0.05; and, Drug 1 x Drug 
2 x Drug 3, F(1, 54) = 7.474, p< 0.01. 
Post hoc pairwise comparisons (LSD) showed that subjects in Groups NaCl-
NaCl-LiCl, LPS-NaCl-LiCl, and LPS-LPS-LiCl spent significant more time moving 
horizontally in the previously drug-paired chamber, relative to all other groups (p’s< 
0.001). Rats pre-treated with LPS during LiCl conditioning (Group NaCl-LPS-LiCl) 
spent significantly less time moving horizontally relative to all other LiCl-treated groups 
(p’s< 0.001), and did not significantly differ from NaCl controls. 
In the previously saline-paired chamber, rats in Group NaCl-LPS-NaCl spent 
significantly more time moving horizontally relative to all other groups (p’s< 0.01), 
except Groups LPS-NaCl-NaCl and NaCl-NaCl-NaCl. Means and S.E.M are depicted in 
Figure 9. 
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Figure 9. Means and S.E.M for time spent moving horizontally in each 
chamber on the test day. LiCl-treated rats spent significantly more time moving in 
the Drug (LiCl)-Paired chamber relative to NaCl controls, unless rats were pre-
treated with LPS (adulthood only) 90 minutes prior to conditioning (p’s < .05). Rats 
treated with LPS in adolescence and adulthood did not show this effect (p’s< 0.05) 
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4.5.4.4 Number of Vertical Movements 
(movements/min) 
 The ANOVA revealed significant main effects of Chamber (drug-paired or saline-
paired), F(1, 54) = 27.148, p< 0.0001; and, Drug 3 (LiCl or NaCl), F(1, 54) = 16.778, p< 
0.0001. Significant interactions were found between Chamber x Drug 3, F(1, 54) = 
62.046, p< 0.0001; and, Chamber x Drug 1 (pubertal LPS or NaCl) x Drug 2 (adult LPS 
or NaCl), F(1, 54) = 11.044, p< 0.01. 
 Post hoc pairwise comparisons (LSD) showed that subjects in Groups NaCl-
NaCl-LiCl, LPS-NaCl-LiCl, and LPS-LPS-LiCl displayed a significantly greater number 
of vertical movements, relative to all other groups (p’s< 0.05), in the previously drug-
paired chamber. Rats pre-treated with LPS during LiCl conditioning (Group NaCl-LPS-
LiCl) showed a significantly smaller number of vertical movements relative to all other 
LiCl-treated rats (p’s< 0.05), but a significantly higher number of vertical movements 
relative to rats in Groups LPS-NaCl-NaCl and NaCl-LPS-NaCl (p’s< 0.05), and did not 
differ significantly from Groups NaCl-NaCl-NaCl and LPS-LPS-NaCl.  
 In the previously saline-paired chamber, rats in Group LPS-NaCl-NaCl displayed 
significantly more vertical movements, relative to all other groups (p’s< 0.05), except 
Groups NaCl-LPS-NaCl and NaCl-LPS-LiCl; and, Group NaCl-LPS-NaCl displayed 
significantly more vertical movements relative to all other groups (p’s< 0.05), except for 
Group LPS-NaCl-NaCl. Means and S.E.M are depicted in Figure 10. 
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Figure 10. Means and S.E.M for the number of vertical movements on the 
test day. LiCl-treated rats reared significantly more in the Drug (LiCl)-Paired 
chamber relative to NaCl controls, regardless of LPS treatment (p’s< 0.05) 
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4.5.4.5 Vertical Movement Time (s/min) 
 The ANOVA revealed significant main effects of Chamber (drug-paired or saline-
paired), F(1, 54) = 26.698, p< 0.0001; and, Drug 3 (LiCl or NaCl), F(1, 54) = 9.467, p< 
0.01. Significant interactions were found between Chamber x Drug 3, F(1, 54) = 61.445, 
p< 0.0001; and, Chamber x Drug 1 (pubertal LPS or NaCl) x Drug 2 (adult LPS or 
NaCl), F(1, 54) = 7.617, p< 0.01. 
 Post hoc pairwise comparisons (LSD) showed that subjects in Groups NaCl-
NaCl-LiCl, LPS-NaCl-LiCl, and LPS-LPS-LiCl spent significantly more time moving 
vertically, relative to all other groups (p’s< 0.05), in the previously drug-paired chamber. 
Rats pre-treated with LPS during LiCl conditioning (Group NaCl-LPS-LiCl) spent 
significantly less time moving vertically, relative to all other LiCl-treated groups (p’s< 
0.05), but spent more time moving vertically relative to Groups LPS-NaCl-NaCl and 
NaCl-LPS-NaCl (p’s< 0.05), and did not differ significantly from Groups NaCl-NaCl-
NaCl and LPS-LPS-NaCl. 
 In the previously saline-paired chamber, Groups LPS-NaCl-NaCl and NaCl-LPS-
NaCl spent significantly more time moving vertically, relative to all other groups (p’s< 
0.05), except for Group NaCl-LPS-LiCl. Due to the similarity of this variable with 
Number of Vertical Movements, no figure is provided. 
 
4.6 Discussion 
The aims of the present study were 4-fold: to examine Conditioned Place 
Avoidance (CPA) behavior in adult female Long-Evans rats, and the effects of 
Conditioning Phase pre-treatment with LPS on the establishment of these conditioned 
behaviors; and, to examine the effects of a peripubertal (6 weeks old) LPS challenge on 
the acquisition of  LiCl-induced context conditioning, as well as, to a homotypic LPS 
challenge in adulthood. Our hypotheses were mainly supported. As expected, female rats 
successfully acquired conditioned place avoidance, evidenced by shorter durations of 
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time spent in the previously drug-paired chamber, as well as, increased frequencies of 
rearing and horizontal movements, relative to controls. As predicted, LPS pre-treatment 
was shown to block the formation of CPA, evidenced by similar durations spent in each 
chamber on the drug-free test day, durations that did not differ significantly from a saline 
control. The hypothesis that peripubertal LPS challenge would alter CPA learning in 
adulthood was unsupported. Female rats that were administered a pubertal LPS challenge 
showed no sign of learning decrements, relative to females treated with saline at 6 weeks 
old.  
Interestingly, it was found that females treated with LPS during the peripubertal 
period displayed tolerance-like behavior following a homotypic LPS challenge in 
adulthood. Females treated with LPS at both time points failed to show significant 
reductions in body weight, nor did LPS in adulthood successfully block CPA 
conditioning. The current study provides the following novel findings: a) LiCl conditions 
robust Conditioned Place Avoidance in female rats; b) LPS pre-treatment blocks the 
acquisition of Conditioned Place Avoidance; c) LPS treatment during the sensitive 
peripubertal phase of development leads to tolerance to further immune challenge with 
LPS in adulthood, including the acute-phase response and learning impairments that have 
been shown to follow LPS treatment. Each finding is further discussed below. 
4.6.1 LiCl-induced conditioned place avoidance 
It was found that adult female Long Evans rats condition place (i.e., context) 
avoidant and aversion-related behaviors following LiCl conditioning, which is consistent 
with previous studies demonstrating CPA in male subjects (Tenk et al., 2005). LiCl-
treated female rats spent significantly less time in the previously drug-paired chamber, 
relative to saline controls; and, during their time spent in the previously drug-paired 
chamber, LiCl-treated subjects also showed significantly higher frequencies of aversion-
related behaviors, such as, further distances travelled, more time moving around the 
chamber horizontally, and more time spent rearing, relative to saline controls and, again, 
Group NaCl-LPS-LiCl. In fact, the current results present robust conditioning effects of 
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LiCl at a dose of 96 mg/kg, which were not as clear in male subjects (Tenk et al., 2005), 
highlighting the need to examine place avoidance responses in female subjects. 
The results of the current study are consistent, in part, with previous studies that have 
examined conditioned disgust behavior in female rats. Females have been shown to 
display dose-related increases in conditioned ‘gaping’ behavior on the drug-free Test Day 
of the rodent model of Anticipatory Nausea. Anticipatory Nausea (AN) is a classically 
conditioned response in humans where the previous pairing of a salient context (e.g., 
hospital) with a nausea-inducing stimulus (e.g., chemotherapy treatment) leads to the 
establishment of anticipatory nausea and/or vomiting upon re-exposure to that 
environment, prior to actual drug treatment (Molassiotis, 2005). This phenomenon has 
been modelled in the rat using a context-based conditioning paradigm, wherein rats learn 
to associate a distinct contextual chamber with “feelings” of nausea produced by LiCl 
treatment, and subsequently retrieve these associations by displaying aversion-related 
behaviors, such as, “conditioned gaping”, in response to re-exposure to the distinct 
context in the absence of drug treatment (see Chan et al., 2009; Cloutier et al., 2012 a,b; 
Limebeer et al., 2006; Parker et al., 2008) 
4.6.2 Lipopolysaccharide effects 
4.6.2.1 Acute LPS treatment during LiCl conditioning 
 LPS treatment significantly reduced body weight in both groups pre-treated with 
LPS during adulthood. Subjects in Groups NaCl-LPS-NaCl and NaCl-LPS-LiCl lost 
significantly more body weight following the first conditioning day, relative to controls. 
This is consistent with prior reports of tolerance development in female rats. Females 
treated with LPS have been shown to develop tolerance to the acute-phase sickness 
behaviors after the first treatment, unless each of the two treatments occurs during the 
proestrous phase of the cycle (Engeland et al., 2006).  
LPS pre-treatment in adulthood, prior to LiCl conditioning, prevented the 
establishment of CPA. Subjects in Group NaCl-LPS-LiCl spent significantly more time 
in the previously drug-paired chamber relative to other LiCl-treated groups and was 
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similar to that of saline controls. LPS treatment has been shown to interfere with the 
establishment of other forms of conditioned behavior, such as, conditioned taste aversion 
and anticipatory nausea (Chan et al., 2009; Chan et al., 2013; Cloutier et al., 2012 a,b; 
Cloutier et al., 2016 a). However, until now the effects of LPS have not been investigated 
in the CPA paradigm, in males or females. Thus, this study demonstrates that LPS 
disrupts CPA acquisition which adds to previous work showing that LPS disrupts 
place/context aversion (i.e., anticipatory nausea). 
4.6.2.2 Peripubertal LPS treatment and learning in 
adulthood 
 Body weight loss consistent with previous studies in adult subjects was observed 
24 h following LPS treatment at 6 weeks old. Peripubertal females treated with LPS at 
this time point lost significantly more weight relative to saline controls. Furthermore, no 
disruptions in regular estrous cycling were observed following peripubertal LPS 
challenge. LPS-treated females exhibited 4-day cycles in adulthood comparable with 
those of non-LPS treated controls. 
Treatment with LPS at 6 weeks old had no effect on the acquisition of CPA 
behavior in adulthood. Group LPS-NaCl-LiCl (i.e., subjects treated with LPS in 
adolescence and conditioned with LiCl in adulthood) spent similar amounts of time in the 
previously drug-paired chamber relative to other LiCl-treated groups, which was also 
significantly less time spent in the chamber relative to controls. Thus, a single LPS 
challenge at 6 weeks old does not influence learning in the CPA paradigm in the adult 
female Long Evans rat. 
4.6.2.3 LPS challenge at 6 weeks old and adult 
homotypic challenge during CPA conditioning 
 Interestingly, subjects treated with LPS at both time points- in adolescence and 
adulthood- behaved differently than predicted. It was hypothesized that subjects treated 
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with LPS at both 6 weeks old and in adulthood might show exacerbated acute-phase 
responses to LPS in adulthood, relative to subjects treated with LPS in adulthood only. 
 Female rats treated with LPS at 6 weeks old displayed tolerance-like behavior to 
homotypic challenge in adulthood. Females in Groups LPS-LPS-NaCl and LPS-LPS-
LiCl did not exhibit significant losses in body weight relative to saline controls, and 
retained body weight relative to subjects treated with LPS in adulthood only (Groups 
NaCl-LPS-NaCl and NaCl-LPS-LiCl). Likewise, female rats treated with LPS at both 
time points failed to show locomotor decrements that are typically observed during the 
acute-phase response as the animal conserves energy. It was hypothesized that a 
homotypic challenge with LPS in adulthood might lead to exacerbated immune 
responses; however, subjects given a homotypic drug challenge actually failed to 
demonstrate the acute-phase response sickness behaviors that typically follow LPS 
treatment. This finding was inconsistent with previous work carried out in male and 
female rat neonates, where it was shown that LPS treatment in early life led to 
exacerbated responses to homotypic challenge in male rats, but normal responses in 
female rats (Tenk et al., 2005).  
 In addition, LPS treatment at 6 weeks of age followed by adult homotypic 
challenge during the conditioning phase of the CPA paradigm lead to tolerance-like 
effects to the learning and memory impairments (i.e., central effects) that have been 
shown to follow treatment. Females in Group LPS-LPS-LiCl, those treated at both time 
points with LPS and conditioned with lithium, spent significantly less time in the 
previously drug-paired chamber relative to saline controls and subjects in Group NaCl-
LPS-LiCl. Furthermore, time spent in the previously drug-paired chamber did not differ 
significantly from other LiCl-conditioned subjects that were pretreated with saline. 
Although LPS pretreatment during conditioning was shown to block CPA learning in 
those subjects treated with saline at 6 weeks old, this learning impairment was not 
observed when subjects were treated with LPS during the peripubertal phase. Thus, these 
results demonstrate that a single immune challenge with LPS at a sensitive developmental 
time point, followed by LPS pretreatment during LiCl-induced CPA conditioning, 
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prevents LPS from attenuating conditioned avoidant and aversive behavior in this 
paradigm, evidence for tolerance-like effects to LPS treatment. 
 This finding was unexpected, and in part, inconsistent with previous work. It has 
been shown that tolerance to the acute-phase behavioral response following LPS 
treatment does not influence the learning and memory effects of the drug. Firstly, during 
the conditioning phase of either the CTA or anticipatory nausea paradigms, subjects 
develop tolerance to LPS, such that significant losses in body weight and decrements in 
locomotor behavior are only observed after the first one or two treatments. In these 
experiments, the drug-free test day for conditioned aversive responding always occurs 
during a state of tolerance to the acute-phase behavioral response (i.e., anorexia) 
produced by LPS, yet the learning and memory impairments persist (Chan et al., 2009; 
Chan et al., 2013; Cloutier et al., 2012a, b; Cross-Mellor et al., 2009). 
 One study examined the effects of LPS pretreatment on the acquisition of AN in 
rats that were tolerant to LPS prior to the conditioning phase treatments (Chan et al., 
2013). Adult male rats were treated with LPS on four separate days (72 h apart) and 
returned to the home cage. Following the tolerance phase, LPS-tolerant and non-tolerant 
male rats were then pretreated with LPS or saline during LiCl-induced anticipatory 
nausea conditioning. It was shown that although subjects were tolerant to LPS just prior 
to conditioning, and remained tolerant to the acute-phase behavior (i.e., body weight 
loss), they continued to display marked learning and memory impairments, evidenced by 
significantly attenuated frequencies of conditioned gaping and other aversion-related 
behaviors, relative to controls. Thus, results of the current study demonstrate a unique 
effect of an adolescent immune challenge with LPS on the effects subsequent LPS 
treatment, and how homotypic challenge influences learning and memory in the CPA 
paradigm. 
The rodent model of AN measures aversion-related responses to involuntary 
exposure to a context, and the CPA test allows the subject to move between the 
previously drug- or saline-paired chambers freely, and thus measures voluntary 
avoidance behavior. However, in both paradigms, the negative association formed 
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between a salient context and the effects of LiCl treatment is blocked by pre-treatment 
with LPS during the Conditioning Phase. In regards to taste + illness associations, LPS 
has been shown to significantly attenuate the formation of active aversion-related disgust 
behavior in the Taste Reactivity Test (TRT) for Conditioned Taste Aversion (CTA; 
Cross-Mellor et al., 2009), but has also been shown to serve as an unconditioned stimulus 
in the condition taste avoidance paradigm (Cross-Mellor et al., 2004). Conversely, LPS 
treatment blocked the formation of conditioned taste avoidance in a simultaneous 
conditioning paradigm for taste avoidance and context aversion (i.e., AN) (see Cloutier et 
al., 2012). As aforementioned, it should be noted that the administration of a taste cue by 
an intravascular route might provide a weakened stimulus, relative to stimuli 
administered orally, and thus, might produce weaker conditioned responses to the 
Conditioned Stimulus (Cloutier et al., 2012).  
Immune challenge with LPS during the peripubertal phase of development, and 
how it affects future behavioral outcomes, has not been extensively examined in males or 
females. Many inflammation-derived developmental models of disorders involve 
perinatal LPS challenges, making the current findings hard to compare. To the best of our 
knowledge, this is the first study to show that peripubertal immune challenge with LPS at 
6 weeks old in the rat leads to tolerance-like behavior to homotypic challenge in 
adulthood. In neonatal male rats, LPS challenge on postnatal days 3 and 5 led to an 
exacerbated acute-phase response following homotypic challenge in adulthood; however, 
normal acute-phase responses are observed following the same treatment in females 
(Tenk et al., 2008). Adult male rats have been shown to exhibit greater losses in body 
weight, relative to female rats, following LPS treatment in adulthood, with female rats 
showing faster tolerance rates (Engeland et al., 2003; Engeland et al., 2006). 
Furthermore, long-term alterations in the anxiolytic effects of sex hormones, such as, 
estrogen, have been observed following peripubertal immune challenges in female mice 
(Blaustein et al., 2011), in addition to the loss of estrogen-induced cognitive enhancement 
in some tasks (Blaustein et al., 2013).  
4.6.3 Putative Mechanisms 
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Similar to AN, the acquisition of CPA relies on the association of feelings of 
nausea with a specific context, thus, it is likely that this task is largely hippocampus-
dependent (Kranjac et al., 2012; Limebeer et al., 2006). Here, we discuss the putative 
mechanisms of LPS-induced memory disruptions in the form of inhibited consolidation 
processes in the hippocampus. Indeed, there is evidence suggesting that LPS treatment 
inhibits aversion conditioning by disrupting memory consolidation processes. 
Examination of LPS-induced chronic neuroinflammation on the induction of NMDA-
dependent, and NMDA-independent, long-term potentiation (LTP) shows that 
intracerebroventricular administration of LPS produces significant spatial memory 
impairment in the Morris water maze (Min et al., 2009). LPS treatment also impaired the 
ability to form representations of distinct contexts in a contextual fear conditioning 
paradigm, as demonstrated by a reduction in freezing responses upon re-exposure to a 
context previously paired with an aversive foot shock in LPS-treated rats (Pugh et al., 
1998). In both studies, it was suggested that LPS could affect the functioning of the 
hippocampus. Recordings of postsynaptic potentials showed that the induction of 
NMDA-dependent and NMDA-independent LTP were impaired in the Schaffer 
collateral-CA1 synapse of the hippocampus (Min et al., 2009). 
Contextual fear conditioning has been shown to be, at least in part, a 
hippocampus-dependent learning paradigm, as demonstrated by the elimination of 
contextual fear conditioned responses after hippocampal lesions one day following 
conditioning (Kim & Fanselow, 1992). Tanaka et al. (2006) reported that LPS 
administration to the CA1 region of the hippocampus activated microglial cells and 
resulted in an increased production of IL-1β and TNF-α in this region. After 5 days of 
injections, it was found that long-term activation of microglia, induced by LPS, resulted 
in a decrease of glutamatergic transmission and learning and memory impairments 
without neuronal cell death (Tanaka et al., 2006). 
Kranjac et al. (2012) showed that a single LPS injection, following contextual fear 
conditioning training, not only impaired memory consolidation, but could also disrupt 
memory reconsolidation processes in mice. This was evidenced by a decrease in freezing 
responses in LPS-treated mice, along with heightened peripheral and central cytokine and 
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chemokine levels, and significantly decreased brain-derived neurotrophic factor (BDNF) 
mRNA expression in the hippocampus and cortex (Kranjac et al., 2012). 
It has been shown that peripheral inflammation by LPS causes a reduction of 
trophic supply in the brain (Schnydrig et al., 2007). Neurotrophins, such as BDNF and 
nerve growth factor (NGF), are known to play an important role in synaptic plasticity and 
long-term potentiation (Schnydrig et al., 2007). An experiment by Hennigan, Trotter, & 
Kelly (2007) demonstrated that synaptic plasticity in the dentate gyrus of the 
hippocampal complex is related to neurotrophin signaling changes, and that the 
disruption of these changes in plasticity by LPS may be partially due to a strong effect on 
these signaling cascades. Guan and Fang (2006) found that LPS treatment decreased 
BDNF expression in not only the hippocampus, but also the frontal, parietal, temporal, 
and occipital cortices. LPS also exerts a depressive effect on the expression of other 
neurotrophins, such as, NGF and neurotrophic factor 3 (NT-3), where expression was 
significantly reduced in cortical regions, as well as, the hippocampus (Guan & Fang, 
2006). 
4.6.4 Conclusions 
 The current study examined conditioned place avoidance (CPA) learning in adult 
female Long Evans rats, the effect of acute LPS treatment on CPA learning, and, the 
effects of peripubertal immune challenge on CPA learning, as well as, responses to 
homotypic drug challenge. It was found that females condition robust LiCl-induced place 
avoidances, and that this form of conditioned behavior is blocked following immune 
system stimulation with LPS. Furthermore, LPS challenge at 6 weeks old failed to alter 
CPA learning in adulthood, and led to peripheral and central tolerance-like behavior in 
those subjects administered a homotypic drug challenge in adulthood. To best of our 
knowledge, this was the first study to demonstrate these findings in female rats. Future 
studies should evaluate the effects of peripubertal immune system challenges in males, 
and whether locomotor variables observed in the CPA paradigm might correlate to active 
aversion-related behavior (i.e., gaping frequencies) in the rodent model of anticipatory 
nausea. 
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Chapter 5 
5 General Discussion 
The current thesis examined sex differences in context-based conditioned disgust 
behaviours in the rat, using the rodent models of anticipatory nausea and conditioned 
place avoidance. Among cancer patients receiving chemotherapy treatment, anticipatory 
nausea and taste avoidance produce aversive conditioning consequences to the treatment 
(Molassiotis, 2005; Morrow et al., 1998; Morrow, Roscoe, Korshner, Hynes, & 
Rosenbluth, 1998). Importantly, evidence suggests that there is a sex difference in the 
onset and severity of conditioned nausea responses, where females are shown to be more 
susceptible relative to males (Fetting et al., 1983; Hilarius et al., 2012; LeBaron et al., 
1988; Williams et al., 1980).  
The second aim of this thesis was to evaluate the effects of Gram-negative 
endotoxin, lipopolysaccharide (LPS), treatment on the establishment of such forms of 
conditioned aversion-related disgust behavior. Previous studies have shown that LPS 
blocks the acquisition of LiCl-induced aversion-related behaviours, such as conditioned 
gaping behavior in the rodent models for anticipatory nausea and conditioned taste 
aversion, in male rats (Chan et al., 2009; Cloutier et al., 2012 b; Cross-Mellor et al., 
2009). However, until now, these effects had not yet been evaluated in female subjects, 
even though sex differences in the prevalence and severity of inflammation-related 
disease exist in the human population.  
For example, Women comprise 60% and 80% of the populations suffering from 
asthma (Tam et al., 2011) and autoimmune disease (Voskuhl, 2011), respectively; and, 
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are 2-6 x more likely to die from H5N1 Avian influenza, relative to men (Klein, Pekosz, 
Passaretti, Anker, & Olukoya, 2010). Furthermore, a greater incidence of 
anxiety/depression-related disorders (for review, see Altemus, Sarvaiya & Epperson, 
2014), as well as, neurodegenerative disease (For review, see Rocca, Mielke, Vemuri & 
Miller, 2014), are observed in women- all of which have been associated with pro-
inflammatory pathology (Abbott et al., 2015; Raz, Knoefel & Bhaskar, 2016; 
Vivekanantham et al., 2015). 
In Chapter 2, the rodent model of anticipatory nausea (AN) was employed to 
examine the ability of female rats to associate “feelings” of disgust with a distinct context 
and to test the effects of immune system stimulation on the development these 
conditioned behaviours (e.g. conditioned gaping, paw treading, chin rubbing). As 
previous studies have shown, LPS pretreatment during the LiCl conditioning phase led to 
significantly attenuated frequencies of aversion-related disgust behavior, relative to males 
pretreated with saline prior to LiCl. LPS also significantly attenuated conditioned disgust 
in LiCl-treated adult female rats. However, females pretreated with saline followed by 
128 mg/kg LiCl displayed significantly higher conditioned gaping frequencies when re-
exposed to the distinct context, relative to males treated with the same dose of LiCl. To 
the best of our knowledge, this was the first study to demonstrate a significant sex 
difference in conditioned disgust using the rodent model of anticipatory nausea. 
In order to investigate this sex difference further, in Chapter 3 male and female 
rats were conditioned with either 0 (saline), 64, 96, or 128 mg/kg and exposed to a 
distinct context. The results showed a dose-related sex difference, evidenced by 
significantly higher gaping frequencies in females relative to males in those subjects 
132 
 
 
 
treated with either 96 or 128 mg/kg LiCl, but not the 64 mg/kg dose. In this study, not 
only was the previous sex difference in gaping behaviour replicated, but it was shown to 
be dose- and sex- dependent. 
To date, very few studies have examined sex differences in conditioned disgust, 
even though human examples strongly suggest that nausea has more of an impact on 
female health and well-being, relative to males. In Chapter 4, we examined conditioned 
place avoidance (CPA) behavior in adult female rats. It was found that LiCl, at a dose of 
96 mg/kg, conditioned significant avoidant behavior, relative to saline-treated subjects. 
LiCl-treated females spent significantly less time in the previously drug-paired chamber 
relative to controls, and relative to the amount of time spent in the previously saline-
paired chamber. Also, LiCl-treated rats displayed significantly higher frequencies of 
locomotor behavior, relative to controls, indicative of agitation or aversion.  
Taken together with the findings in Chapter 2, a robust sex difference in the 
establishment of context-based, LiCl-induced conditioned disgust and conditioned 
avoidance behaviours has been demonstrated. Females show significantly higher, dose-
related increases in conditioning gaping behavior, relative to males, which provides a 
valuable preclinical tool for evaluating not only the efficacy of anti-nausea medications, 
but also the noxious side-effects of therapeutic drug treatment, such as, lithium used to 
treat depression-related mental health disorders.  
The effects of LPS on the establishment of CPA were also examined. As 
predicted, LPS blocked CPA behavior, evidenced by similar lengths of time spent in both 
chambers that did not differ from saline controls. The third aim of this experiment was to 
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examine the effects of a single immune challenge with LPS during an important stage of 
development (peripubertal phase) on the development of CPA behavior in adulthood, as 
well as, on the response to a subsequent LPS challenge in adulthood. Results showed that 
a single LPS challenge at 6 weeks of age had no effect on the establishment of CPA in 
adulthood.  
Interestingly, female rats that were treated with LPS at 6 weeks of age and again 
in adulthood displayed a tolerance-like response the adult challenge. Indeed, female rats 
treated with LPS at both time points did not lose significant amounts of body weight, 
relative to rats treated with LPS in adulthood only; and, these subject also did not show 
significant reductions in locomotor behavior. Furthermore, in female rats that were 
treated with LPS at 6 weeks of age, LPS treatment in adulthood failed to block the 
establishment of CPA.  
To the best of our knowledge, this was the first study to evaluate CPA learning in 
female subjects, and the first study to examine the effects of LPS on CPA learning and 
memory. Results from this experiment support prior evidence (see Blaustein et al., 2011; 
Blaustein et al., 2013), that suggests that immune challenge during this developmental 
time period leads to long-lasting changes in behavior, by showing that the acute-phase 
response and typical memory impairments previously observed following LPS treatment 
are absent. The measures in this study were behavioral in nature, and hormone 
concentrations were not measured at any time point, but estrous cycles were tracked and 
found to not be disrupted by any drug treatment. However, it has been shown that in 
female Wistar rats that received an adolescent stressor, LPS challenge in adulthood led to 
increased levels of circulating estrogen (Pyter et al., 2013). In healthy controls, estrogen 
134 
 
 
 
was positively correlated to microglial gene expression in the hippocampus, but this 
relationship was not observed in females who received an adolescent stressor (Pyter et al, 
2013). It was suggested that estradiol may have a protective effect against stress-induced 
neuroinflammation (Pyter et al., 2013), and if so, it is plausible that a second immune 
challenge with LPS in adulthood may increase estradiol levels without the associated 
increases in microglial gene expression in the hippocampus — a structure known to play 
a critical role in the formation of context-based memories.  
5.1 Conclusions 
 In the present thesis, sex differences in the establishment of conditioned gaping in 
the rodent model of anticipatory nausea and the response to LPS treatment were 
examined. Furthermore, the effect of LPS pretreatment on CPA learning was evaluated 
for the first time in female subjects, including the influence of an adolescent (i.e., 
peripubertal) immune challenge with LPS on subsequent LPS administrations in 
adulthood. 
 It was shown that female rats condition significantly stronger conditioned gaping 
responses to a context previously paired with LiCl, and that this difference is dose-
related. LPS disrupted the establishment of conditioned gaping behaviour in both male 
and female groups, although a ceiling effect cannot be ruled out. Future studies might 
examine lower doses of LPS in order to determine if sex differences in the response to 
endotoxin might be present. 
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Future studies should also evaluate putative changes in circulating estradiol levels 
following adolescent immune challenge and measure corresponding microglial 
expression in the brain. Given that anxiety and depression-related disorders are more 
common in females (see Fitelson & McGibbon, 2016 for review), and that the onset of 
these behaviours often correlates to adolescence (see Guyer et al., 2016 for review), it 
follows that this time period might provide a valuable time point at which to test the 
effects of significant stressors on mental health outcomes in those disorders associated 
with neuroinflammation, such as, depression and anxiety (Chesnokova et al., 2016), for 
which sex differences in the population are observed. Furthermore, the effects of a 
peripubertal immune challenge on the response to LPS treatment in adulthood should be 
evaluated in males, as male rats have shown exacerbated responses to homotypic 
challenge if they were treated neonatally with LPS (Tenk et al., 2008). 
There is still much to be learned about nausea- and inflammation-induced changes 
in behavior; however, the current thesis was the first to demonstrate a robust sex 
difference in the development of conditioned nausea-related behaviour in the rodent 
model of anticipatory nausea; and, it was the first to examine CPA learning in female 
Long Evans rats, as well as, the first study to examine the influence of peripubertal and 
adult immune system stimulation on CPA acquisition.  
In the human population, evidence suggests that the observed sex differences in 
the onset and severity of nausea begin to emerge in adolescence (Lebaron et al., 1988), 
which indicates the influence of sex steroids. Since it has also been shown that anxiety 
increases the likelihood of developing Anticipatory Nausea (Andrykowski, 1990) it 
would follow that significant immune system stimulation during a sensitive period of 
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development might lead to changes in circulating hormone concentrations, and, in the 
corresponding immune responses to further immune challenges in adulthood. It is likely 
that the nausea-associated malaise following LiCl treatment is responsible for the 
development of conditioned place avoidance in female rats; however, this should be 
further evaluated using a method that allows for the observation of both chamber dwell 
times, as well as, specific conditioned disgust behavior, such as gaping. 
The current results demonstrate a method with which sex differences in the 
efficacy of anti-nausea drug treatments can be tested, or the evaluation of noxious drug 
side-effects. In addition, this thesis has demonstrated that a peripubertal immune 
challenge with LPS at 6 weeks of age leads to a tolerance-like response to both the acute-
phase response and memory impairments typically associated with LPS treatment, and 
thus provides support for the notion that adolescence presents a critical time point in 
development when the experience of a stressor may alter the course of future 
development, leading to lasting changes in behaviour.  
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